<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">92469</article-id><article-id pub-id-type="doi">10.7554/eLife.92469</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.92469.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>β-catenin inhibition disrupts the homeostasis of osteogenic/adipogenic differentiation leading to the development of glucocorticoid-induced osteonecrosis of the femoral head</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-334543"><name><surname>Xia</surname><given-names>Chenjie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5987-4146</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-334567"><name><surname>Xu</surname><given-names>Huihui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334568"><name><surname>Fang</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334569"><name><surname>Chen</surname><given-names>Jiali</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334570"><name><surname>Yuan</surname><given-names>Wenhua</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334571"><name><surname>Fu</surname><given-names>Danqing</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334572"><name><surname>Wang</surname><given-names>Xucheng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334573"><name><surname>He</surname><given-names>Bangjian</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334574"><name><surname>Xiao</surname><given-names>Luwei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334575"><name><surname>Wu</surname><given-names>Chengliang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334576"><name><surname>Tong</surname><given-names>Peijian</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-171310"><name><surname>Chen</surname><given-names>Di</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4258-3457</contrib-id><email>di.chen@siat.ac.cn</email><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-334577"><name><surname>Wang</surname><given-names>Pinger</given-names></name><email>pingerwang@zcmu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-260684"><name><surname>Jin</surname><given-names>Hongting</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8795-0874</contrib-id><email>hongtingjin@163.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04epb4p87</institution-id><institution>Institute of Orthopedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03et85d35</institution-id><institution>Department of Orthopedic Surgery, the Affiliated Lihuili Hospital of Ningbo University</institution></institution-wrap><addr-line><named-content content-type="city">Ningbo</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04epb4p87</institution-id><institution>The First College of Clinical Medicine, Zhejiang Chinese Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04epb4p87</institution-id><institution>School of Basic Medical Sciences, Zhejiang Chinese Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05m1p5x56</institution-id><institution>Department of Orthopedic Surgery, the First Affiliated Hospital of Zhejiang Chinese Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gh4er46</institution-id><institution>Faculty of Pharmaceutical Sciences, Shenzhen Institute of Advanced Technology</institution></institution-wrap><addr-line><named-content content-type="city">Shenzhen</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ji</surname><given-names>Yaoting</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/033vjfk17</institution-id><institution>Wuhan University</institution></institution-wrap><country>China</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Weigel</surname><given-names>Detlef</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0243gzr89</institution-id><institution>Max Planck Institute for Biology Tübingen</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>20</day><month>02</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP92469</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-09-20"><day>20</day><month>09</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-10-06"><day>06</day><month>10</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.10.04.560853"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-11-01"><day>01</day><month>11</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92469.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-01-24"><day>24</day><month>01</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92469.2"/></event></pub-history><permissions><copyright-statement>© 2023, Xia, Xu et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Xia, Xu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-92469-v1.pdf"/><abstract><p>Glucocorticoid-induced osteonecrosis of the femoral head (GONFH) is a common refractory joint disease characterized by bone damage and the collapse of femoral head structure. However, the exact pathological mechanisms of GONFH remain unknown. Here, we observed abnormal osteogenesis and adipogenesis associated with decreased β-catenin in the necrotic femoral head of GONFH patients. In vivo and in vitro studies further revealed that glucocorticoid exposure disrupted osteogenic/adipogenic differentiation of bone marrow mesenchymal cells (BMSCs) by inhibiting β-catenin signaling in glucocorticoid-induced GONFH rats. Col2<sup>+</sup> lineage largely contributes to BMSCs and was found an osteogenic commitment in the femoral head through 9 mo of lineage trace. Specific deletion of β-catenin gene (<italic>Ctnnb1</italic>) in Col2<sup>+</sup> cells shifted their commitment from osteoblasts to adipocytes, leading to a full spectrum of disease phenotype of GONFH in adult mice. Overall, we uncover that β-catenin inhibition disrupting the homeostasis of osteogenic/adipogenic differentiation contributes to the development of GONFH and identify an ideal genetic-modified mouse model of GONFH.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>osteonecrosis of the femoral head</kwd><kwd>β-catenin</kwd><kwd>Col2<sup>+</sup> lineage</kwd><kwd>Glucocorticoid</kwd><kwd>osteogenic/adipogenic differentiation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd><kwd>Rat</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82104885</award-id><principal-award-recipient><name><surname>Xia</surname><given-names>Chenjie</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82074469</award-id><principal-award-recipient><name><surname>He</surname><given-names>Bangjian</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004731</institution-id><institution>Natural Science Foundation of Zhejiang Province</institution></institution-wrap></funding-source><award-id>LQ22H270001</award-id><principal-award-recipient><name><surname>Xia</surname><given-names>Chenjie</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004731</institution-id><institution>Natural Science Foundation of Zhejiang Province</institution></institution-wrap></funding-source><award-id>LY21H270008</award-id><principal-award-recipient><name><surname>He</surname><given-names>Bangjian</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004731</institution-id><institution>Natural Science Foundation of Zhejiang Province</institution></institution-wrap></funding-source><award-id>LR23H270001</award-id><principal-award-recipient><name><surname>Jin</surname><given-names>Hongting</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Ningbo medical key discipline</institution></institution-wrap></funding-source><award-id>2022-B01</award-id><principal-award-recipient><name><surname>Xia</surname><given-names>Chenjie</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>Ningbo Top Medical and Health Program</institution></institution-wrap></funding-source><award-id>2022020102</award-id><principal-award-recipient><name><surname>Xia</surname><given-names>Chenjie</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82250710174</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Di</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82161160342</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Di</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Deletion of β-catenin in Col2<sup>+</sup> progenitor cells shifts their commitment from osteoblasts to adipocytes, leading to a full spectrum of disease phenotype of glucocorticoid-induced osteonecrosis of the femoral head in adult mice.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Glucocorticoids, potent immunity regulators, are widely used in the treatment of various autoimmune diseases such as systemic lupus erythematosus, nephrotic syndrome , and rheumatoid arthritis (<xref ref-type="bibr" rid="bib59">Yang et al., 2021</xref>). However, excessive usage of glucocorticoids has been reported to cause severe adverse effects, especially femoral head osteonecrosis in the joint (<xref ref-type="bibr" rid="bib64">Zaidi et al., 2010</xref>; <xref ref-type="bibr" rid="bib40">Tao et al., 2017</xref>). As a destructive joint disease, glucocorticoid-induced osteonecrosis of the femoral head (GONFH) disables about 100,000 Chinese and more than 20,000 Americans annually (<xref ref-type="bibr" rid="bib30">Petek et al., 2019</xref>; <xref ref-type="bibr" rid="bib69">Zhao et al., 2020</xref>), bringing a huge financial burden on the society. Currently, there is no ideal medical treatment for GONFH due to its unclear pathological mechanisms. Most patients eventually have to undergo a joint replacement surgery (<xref ref-type="bibr" rid="bib33">Scaglione et al., 2015</xref>). Therefore, in-depth study of GONFH pathogenesis is urgently needed.</p><p>Previous ex vivo studies on human necrotic femoral heads revealed prominent pathological features of GONFH, including fat droplet clusters, trabecular bone loss, empty lacunae of osteocyte at the early stage and extra subchondral bone destruction, and structure collapse at the late stage (<xref ref-type="bibr" rid="bib31">Qin et al., 2015</xref>; <xref ref-type="bibr" rid="bib43">Wang et al., 2018a</xref>). Glucocorticoid-induced animal models are commonly used to study GONFH pathogenesis, which mimic the early necrotic changes of GONFH but without structure collapse (<xref ref-type="bibr" rid="bib71">Zheng et al., 2018</xref>). Several hypotheses, such as damaged blood supply (<xref ref-type="bibr" rid="bib37">Sun et al., 2021</xref>; <xref ref-type="bibr" rid="bib44">Wang et al., 2018b</xref>), abnormal lipid metabolism (<xref ref-type="bibr" rid="bib22">Lavernia et al., 1999</xref>; <xref ref-type="bibr" rid="bib3">Chang et al., 1993</xref>), and bone cell apoptosis (<xref ref-type="bibr" rid="bib6">Chen et al., 2022</xref>; <xref ref-type="bibr" rid="bib65">Zalavras et al., 2003</xref>), have been proposed to explain the occurrence and development of GONFH. However, the therapies developed according to the guidelines established based on these theories have not been successful in the prevention of GONFH progression. Clinical evidence about the decreased replication and osteogenic differentiation capacity of bone marrow mesenchymal stromal cells (BMSCs) (<xref ref-type="bibr" rid="bib23">Lee et al., 2006</xref>; <xref ref-type="bibr" rid="bib42">Wang et al., 2008</xref>; <xref ref-type="bibr" rid="bib17">Houdek et al., 2016</xref>) and the efficacy of BMSC transplantation (<xref ref-type="bibr" rid="bib47">Wang et al., 2019b</xref>; <xref ref-type="bibr" rid="bib38">Tabatabaee et al., 2015</xref>; <xref ref-type="bibr" rid="bib11">Gangji and Hauzeur, 2005</xref>) in GONFH patients indicate that GONFH might be a BMSC-related disease. BMSCs contain mesenchymal progenitor cells that give rise to osteoblasts and adipocytes, and glucocorticoids have been shown to regulate osteogenic/adipogenic differentiation of BMSCs in vitro (<xref ref-type="bibr" rid="bib60">Yin et al., 2006</xref>; <xref ref-type="bibr" rid="bib15">Han et al., 2019</xref>). Various treatments targeting promoting osteogenic differentiation of BMSCs alleviate early necrotic phenotype in glucocorticoid-induced GONFH animal models (<xref ref-type="bibr" rid="bib5">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="bib72">Zhu et al., 2020</xref>; <xref ref-type="bibr" rid="bib10">Feng et al., 2022</xref>). Thus, we hypothesize that imbalanced osteogenic/adipogenic differentiation of BMSCs plays a dominant role in GONFH pathogenesis. Recent lineage-tracing and single-cell RNA-sequencing studies revealed that BMSCs are a group of heterogeneous multipotent cells (<xref ref-type="bibr" rid="bib12">Gao et al., 2021</xref>), and skeletal-derived mesenchymal progenitor cells, including collagen II (Col2)<sup>+</sup> lineage and Osterix (Sp7)<sup>+</sup> lineage, compose a large proportion of BMSCs (<xref ref-type="bibr" rid="bib29">Ono et al., 2014</xref>; <xref ref-type="bibr" rid="bib27">Liu et al., 2013</xref>). However, which subpopulation of BMSCs significantly contributes to the GONFH pathogenesis remains unknown.</p><p>BMSC differentiation is a complex process and is regulated by multiple signaling pathways. Among them, canonical Wnt/β-catenin signaling functions as a switch in determining osteogenic/adipogenic differentiation of BMSCs (<xref ref-type="bibr" rid="bib35">Song et al., 2012</xref>). When β-catenin is accumulated in the nucleus, it interacts with TCF/Lef transcription factors to activate downstream target genes, including <italic>Runt-related transcription factor 2</italic> (<italic>Runx2</italic>) and <italic>Sp7</italic> (<xref ref-type="bibr" rid="bib63">Yuan et al., 2016</xref>). On the contrary, inhibition of β-catenin induces expressions of <italic>CCAAT/enhancer binding protein alpha</italic> (<italic>Cebpa</italic>) and <italic>peroxisome proliferator-activated receptor gamma</italic> (<italic>Pparg</italic>) for adipogenesis (<xref ref-type="bibr" rid="bib39">Takada et al., 2009</xref>; <xref ref-type="bibr" rid="bib55">Xu et al., 2016</xref>). Our previous study showed a significant decrease in β-catenin in the glucocorticoid-induced GONFH rat model (<xref ref-type="bibr" rid="bib67">Zhang et al., 2019</xref>). Other groups also reported an involvement of β-catenin signaling in GONFH development (<xref ref-type="bibr" rid="bib68">Zhang et al., 2021</xref>; <xref ref-type="bibr" rid="bib4">Chen et al., 2019</xref>; <xref ref-type="bibr" rid="bib70">Zhao et al., 2021</xref>; <xref ref-type="bibr" rid="bib61">Yu et al., 2016</xref>; <xref ref-type="bibr" rid="bib66">Zhang et al., 2015</xref>).</p><p>Here, abnormal osteogenesis and adipogenesis with decreased β-catenin signaling were observed in the necrotic femoral heads of GONFH patients and glucocorticoid-induced GONFH rats. Activation of β-catenin signaling effectively alleviated the necrotic changes in GONFH rats by restoring glucocorticoid exposure-induced imbalanced osteogenic/adipogenic differentiation of BMSCs. Interestingly, specific deletion of β-catenin gene (<italic>Ctnnb1</italic>) in Col2<sup>+</sup> cells, but not Sp7<sup>+</sup>, cells led to a full spectrum of disease phenotype of GONFH in mice even including subchondral bone destruction and femoral head collapse. This study provides novel molecular mechanisms of GONFH pathogenesis and an ideal genetic-modified mouse model for GONFH study.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Abnormal osteogenesis and adipogenesis with decreased β-catenin in necrotic femoral heads of GONFH patients</title><p>To determine the pathogenesis of GONFH, we harvested the surgical specimens from GONFH patients with femoral head necrosis (n = 15) and samples from trauma patients without femoral head necrosis (n = 10). Compared to the non-necrotic femoral heads, we observed subchondral bone destruction (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, black asterisk), liquefied necrotic foci (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, black arrow), and deformed and collapsed outline in the necrotic femoral head. μCT analysis further showed sparse and cracked trabeculae in the collapsed region (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, red box) and liquefied necrotic region (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, yellow box) compared to the corresponding regions (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, white boxes) in the non-necrotic femoral heads, which were further confirmed by the decreased BV/TV, Tb.N, and Tb.Th and increased Tb.Sp (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The representative images of Alcian Blue Hematoxylin (ABH) staining (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) revealed sparse trabeculae, massive accumulated fat droplets (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, black triangles), numerous empty lacunae of osteocytes (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, black arrows), and extensive subchondral bone destruction (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, yellow arrows) in the necrotic femoral heads. Histomorphological quantitative analyses showed decreased trabecular bone area (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), increased fat droplet area (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), and empty lacunae rate (<xref ref-type="fig" rid="fig1">Figure 1F</xref>) in the necrotic femoral heads. TUNEL staining revealed more apoptotic osteocytes in the necrotic femoral heads (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). We then detected the expression of osteogenic (<italic>Runx2</italic>, <italic>Sp7</italic>) and adipogenic (<italic>Fabp4</italic>, <italic>Pparg</italic>, <italic>Cebpa</italic>) marker genes. The results of immunohistochemistry (IHC) staining showed a downregulation of Runx2 and an upregulation of FABP4 in the necrotic regions (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). Western blot analysis showed increased expressions of PPAR-γ and C/EBP-α and a decreased expression of Osterix in the human necrotic femoral head tissues (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). These findings indicate an involvement of abnormal osteogenesis and adipogenesis during GONFH pathogenesis. β-Catenin can regulate osteogenesis and adipogenesis downstream target genes (<italic>Runx2</italic>, <italic>Sp7</italic>, <italic>Fabp4</italic>, <italic>Pparg,</italic> and <italic>Cebpa</italic>) expressions (<xref ref-type="bibr" rid="bib41">Tencerova and Kassem, 2016</xref>). The significant decrease in β-catenin in the necrotic femoral heads (<xref ref-type="fig" rid="fig1">Figure 1G and H</xref>) indicates an important role of β-catenin signaling in GONFH pathogenesis.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Abnormal osteogenesis and adipogenesis with decreased β-catenin signaling in the necrotic femoral heads of glucocorticoid-induced osteonecrosis of the femoral head (GONFH) patients.</title><p>Necrotic (n = 15) and non-necrotic (n = 10) femoral head samples were obtained from GONFH patients or femoral neck fracture patients, respectively. (<bold>A</bold>) Gross anatomy analysis of human necrotic and non-necrotic femoral head samples. Black asterisks: subchondral collapsed region. Black arrows: liquefied necrotic region. (<bold>B</bold>) μCT images of human necrotic and non-necrotic femoral heads. Red and yellow boxed areas: 3D images of subchondral collapsed region and liquefied necrotic region, respectively. White boxed areas: 3D images of corresponding regions in the non-necrotic femoral heads. (<bold>C</bold>) Quantitative analysis of BV/TV, Tb.N, Tb.Th, and Tb.Sp on the necrotic regions. (<bold>D</bold>) Alcian Blue Hematoxylin (ABH) staining of human necrotic and non-necrotic femoral heads. (a, c) High-magnification images of bone marrow; (b, d) high-magnification images of bone trabeculae; yellow arrows: subchondral bone destruction; black arrows: empty lacunae of osteocytes; black triangles: fat droplets. (<bold>E</bold>) Histomorphological quantitative analysis of trabecular bone area and fat droplet area. (<bold>F</bold>) Histomorphological quantitative analysis of empty lacunae rate. (<bold>G</bold>) TUNEL staining of osteocytes in human necrotic and non-necrotic femoral heads. (<bold>H</bold>) Immunohistochemistry (IHC) staining of Runx2 and FABP4 expressions in human necrotic and non-necrotic femoral heads. (<bold>I</bold>) Western blot of β-catenin, Osterix, PPAR-γ, and CEBP/α in human necrotic and non-necrotic femoral heads.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Labeled uncropped western blots for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Raw unedited blots for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig1-data3-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92469-fig1-v1.tif"/></fig></sec><sec id="s2-2"><title>Inhibition of β-catenin signaling leads to abnormal osteogenesis and adipogenesis in glucocorticoid-induced GONFH rats</title><p>To further analyze the role of β-catenin in GONFH pathogenesis, a glucocorticoid-induced GONFH rat model was established by continuous methylprednisolone (MPS) induction, as previously described (<xref ref-type="bibr" rid="bib71">Zheng et al., 2018</xref>). Gross anatomy analysis showed a local melanocratic region on the femoral head surface of GONFH rats without any structure deformity or collapse (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, black arrow). No color change was observed on the femoral head surface from the Wnt agonist 1-treated rats. μCT images and quantitative analysis of bone microstructure showed severe trabecular bone loss in the femoral heads of GONFH rats, especially in the subchondral region (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). Systemic injection of Wnt agonist 1 effectively increased bone mass (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), and alleviated decreased BV/TV, Tb.N, and Tb.Th and increased Tb.Sp in GONFH rats (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). ABH staining and histomorphological quantitative analysis revealed that the GONFH rats presented sparse trabeculae, massive fat accumulation (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, black arrow), and numerous empty lacunae of osteocytes (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, black arrows) in the necrotic region of femoral heads (<xref ref-type="fig" rid="fig2">Figure 2C–E</xref>). However, no subchondral bone destruction, femoral head collapse, and deformity occurred in this GONFH rat model (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). TUNEL staining revealed increased apoptotic osteocytes in the femoral heads of GONFH rats (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). ALP is an osteoblast marker reflecting the capacity of osteogenesis. FABP4 is essential for lipid formation and metabolism. The decreased β-catenin and ALP expressions and increased FABP4 expression confirmed abnormal osteogenesis and adipogenesis during rat GONFH development (<xref ref-type="fig" rid="fig2">Figure 2G and H</xref>), consistent with the findings in human GONFH. Interestingly, activation of β-catenin by systematically injecting Wnt agonist 1 for 6 wk attenuated the early necrotic changes (<xref ref-type="fig" rid="fig2">Figure 2C–F</xref>), and restored ALP and FABP4 expressions in the femoral heads of GONFH rats (<xref ref-type="fig" rid="fig2">Figure 2G and H</xref>). Overall, these data indicate that β-catenin inhibition-induced abnormal osteogenesis and adipogenesis contributes to GONFH pathogenesis.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Systemic injection of Wnt agonist 1 alleviates abnormal osteogenesis and adipogenesis in rat glucocorticoid-induced osteonecrosis of the femoral head (GONFH).</title><p>The rat model of GONFH was established by a co-induction of lipopolysaccharide and methylprednisolone (MPS). The femoral head samples were harvested after GONFH rats were intravenously injected with Wnt agonist 1 for 6 wk. (<bold>A</bold>) Gross anatomy analysis and μCT images of femoral heads in sham, model, and Wnt agonist 1-treated groups. (<bold>B</bold>) μCT quantitative analysis of BV/TV, Tb.N, Tb.Th, and Tb.Sp in each group. (<bold>C</bold>) Alcian Blue Hematoxylin (ABH) staining of femoral heads in each group. (a–c) High-magnification images of the representative region; black arrows: empty lacunae of osteocytes; black triangles: fat droplets. (<bold>D</bold>) Histomorphological quantitative analysis of trabecular bone area and fat droplet area in each group. (<bold>E</bold>) Histomorphological quantitative analysis of empty lacunae rate in each group. (<bold>F</bold>) TUNEL staining of osteocytes in the femoral heads of GONFH rats. (<bold>G, H</bold>) Immunohistochemistry (IHC) staining and quantitative analysis of β-catenin, ALP, and FABP4 in rat femoral heads of each group.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig2-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92469-fig2-v1.tif"/></fig></sec><sec id="s2-3"><title>β-catenin directs dexamethasone-induced osteogenic/adipogenic differentiation of rat BMSCs</title><p>We further investigated cellular mechanisms involved in the necrotic femoral heads of glucocorticoid-induced GONFH rats. Primary bone marrow cells were extracted from the proximal femur of 4-week-old Sprague–Dawley (SD) rats and cultivated to P3. Flow cytometry analysis identified that they were BMSCs, with CD90<sup>+</sup>, CD29<sup>+</sup>, CD45<sup>-</sup>, and CD11b<sup>-</sup> characteristics (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). ALP staining showed that the osteogenic differentiation of BMSCs was significantly inhibited after exposing to 10<sup>2</sup> nM or higher concentration of dexamethasone (Dex) for 7 d (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Oil red O staining showed a progressive adipogenic differentiation of BMSCs with the increased concentration of Dex (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). These findings indicated that increased adipogenic differentiation and decreased osteogenic differentiation of BMSCs caused the abnormal osteogenesis and adipogenesis, finally leading to the femoral head necrosis in GONFH rats. The decreased expressions of β-catenin, Runx2, ALP, and increased expressions of PPAR-γ, CEBP/α further revealed that Dex exposure inhibited β-catenin signaling and redirected BMSCs differentiation from osteoblasts to adipocytes (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>). However, this Dex-induced abnormal differentiation of BMSCs was restored by SKL2001 through activation of β-catenin signaling (<xref ref-type="fig" rid="fig3">Figure 3E–G</xref>). Taken together, these findings suggest that β-catenin inhibition redirects the direction of BMSC differentiation, contributing to the GONFH development.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Activation of β-catenin redirected dexamethasone (Dex)-induced imbalanced osteogenic/adipogenic differentiation of bone marrow mesenchymal cells (BMSCs).</title><p>Primary BMSCs were extracted from the proximal femur of 4-week-old Sprague–Dawley (SD) rats and cultivated to passage 3 for subsequent experiments. (<bold>A</bold>) Flow cytometry analyzing the surface markers of rat BMSCs. (<bold>B</bold>) ALP staining and oil red O staining of BMSCs at the increasing concentrations of Dex. (<bold>C, D</bold>) Western blot and quantitative analysis of β-catenin, Runx2, ALP, PPAR-γ, and CEBP/α in BMSCs at the increasing concentrations of Dex. (<bold>E</bold>) ALP staining and oil red O staining of rat BMSCs at the condition with or without 10<sup>4</sup> nM Dex and 20 μM SKL2001 (an agonist of β-catenin). (<bold>F, G</bold>) Western blot and quantitative analysis of β-catenin, Runx2, ALP, PPAR-γ, and CEBP/α in rat BMSCs at the condition with or without 10<sup>4</sup> nM Dex and 20 μM SKL2001.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig3-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Labeled uncropped western blots for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig3-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Raw unedited blots for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig3-data3-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92469-fig3-v1.tif"/></fig></sec><sec id="s2-4"><title>Loss of function of <italic>Ctnnb1</italic> in Col2<sup>+</sup>-expressing, but not Sp7<sup>+</sup>, cells leads to a GONFH-like phenotype in femoral head</title><p>Skeletal progenitor cells are the major source of BMSCs, and both Col2<sup>+</sup> lineage and Sp7<sup>+</sup> lineage can trans-differentiate into BMSCs (<xref ref-type="bibr" rid="bib12">Gao et al., 2021</xref>; <xref ref-type="bibr" rid="bib29">Ono et al., 2014</xref>). To determine which subset of BMSCs contributes more to GONFH pathogenesis, we generated <italic>Col2a1-CreER<sup>T2</sup>;Ctnnb1<sup>flox/flox</sup></italic> (Ctnnb1<sup>Col2ER</sup>) mice and <italic>Sp7-CreER<sup>T2</sup>;Ctnnb1<sup>flox/flox</sup></italic> (Ctnnb1<sup>Sp7ER</sup>) mice, in which <italic>Ctnnb1</italic> gene was specifically deleted in Col2<sup>+</sup> cells and Sp7<sup>+</sup> cells, respectively. For mapping their cell fate in the femoral head, we induced <italic>Col2a1-CreER<sup>T2</sup>;Rosa26-LSL-tdTomato</italic> (Tomato<sup>Col2ER</sup>) mice and <italic>Sp7-CreER<sup>T2</sup>;Rosa26-LSL-tdTomato</italic> (Tomato<sup>Sp7ER</sup>) mice at 2 weeks old and analyzed at the age of 1 mo. The fluorescent images showed that Col2<sup>+</sup> cells were evidently expressed in the chondrocytes of articular cartilage, secondary ossification center and growth plate (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, white arrowheads), osteoblasts (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, green arrowheads), osteocytes (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, yellow arrowheads), and stromal cells (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, red arrowheads) underneath the growth plate, while Sp7<sup>+</sup> cells were identified only in osteoblasts, osteocytes, and stromal cells underneath the growth plate (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). We then trace Col2<sup>+</sup> lineage for 9 mo and found that Col2<sup>+</sup> chondrocytes in secondary ossification center and growth plate were replaced by Col2<sup>+</sup> osteoblasts, osteocytes, and stromal cells with age (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), and these Col2<sup>+</sup> cells continuously produced osteoblasts and osteocytes in the femoral head (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). These findings indicated the self-renew ability and osteogenic commitment of Col2<sup>+</sup> cells. We also induced Tomato<sup>Col2ER</sup> mice at the age of 1 mo, but identified a poor <italic>Cre</italic>-recombinase efficiency 24 hr and 3 mo later (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). IHC assay showed a significant decrease of β-catenin in the femoral heads of 3-month-old Ctnnb1<sup>Col2ER</sup> mice and Ctnnb1<sup>Sp7ER</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4D and E</xref>), indicating successful establishments of these <italic>Ctnnb1</italic> conditional knockout mouse models.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Fate mapping of Col2<sup>+</sup> cells and Sp7<sup>+</sup> cells in the femoral head.</title><p>Tomato<sup>Col2ER</sup> mice and Tomato<sup>Sp7ER</sup> mice continuously received five doses of tamoxifen (TM) injections (1 mg/10 g body weight) at the age of 2 wk for fate mapping analysis. (<bold>A</bold>) Distributions of Col2<sup>+</sup> and Sp7<sup>+</sup> cells in the femoral heads of 1-month-old Tomato<sup>Col2ER</sup> mice and Tomato<sup>Sp7ER</sup> mice. White arrowheads: chondrocytes; green arrowheads: osteoblasts; yellow arrowheads: osteocytes; red arrowheads: bone marrow stromal cells; GP: growth plate; SOC: second ossification center; BM: bone marrow. (<bold>B</bold>) Lineage trace of Col2<sup>+</sup> cells in the femoral head for 9 mo. a: high-magnification image of bone marrow region. (<bold>C</bold>) Poor <italic>Cre</italic>-recombinase efficiency in the femoral heads of Tomato<sup>Col2ER</sup> mice with TM induction at the age of 1 mo. (<bold>D, E</bold>) Femoral heads were harvested from 3-month-old Ctnnb1<sup>Col2ER</sup> mice and Ctnnb1<sup>Sp7ER</sup> mice to detect expression of β‐catenin. Immunohistochemistry (IHC) staining and quantitative analysis of β-catenin in the femoral heads of 3-month-old Ctnnb1<sup>Col2ER</sup> mice and Ctnnb1<sup>Sp7ER</sup> mice.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig4-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92469-fig4-v1.tif"/></fig><p>Then, we analyzed morphological changes of the femoral heads from 3-month-old Ctnnb1<sup>Col2ER</sup> mice and Ctnnb1<sup>Sp7ER</sup> mice. No change of appearance was observed on the femoral heads both in Ctnnb1<sup>Col2ER</sup> mice and Ctnnb1<sup>Sp7ER</sup> mice compared to <italic>Cre</italic>-negative littermates (<xref ref-type="fig" rid="fig5">Figures 5A</xref> and <xref ref-type="fig" rid="fig6">6A</xref>). μCT images and quantitative analysis of decreased BV/TV, Tb.N, Tb.Th, and increased Tb.Sp indicated that both Ctnnb1<sup>Col2ER</sup> mice and Ctnnb1<sup>Sp7ER</sup> mice presented severe bone loss in the femoral heads (<xref ref-type="fig" rid="fig5">Figures 5B</xref> and <xref ref-type="fig" rid="fig6">6B</xref>). ABH staining and histomorphological analysis further revealed that bone trabeculae were extensively replaced by fat droplet clusters in the femoral heads (especially in the subchondral region) of Ctnnb1<sup>Col2ER</sup> mice (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>), similar to the necrotic femoral heads in GONFH patients and glucocorticoid-induced rat models. However, no fat droplet accumulation but only sparse and thin bone trabeculae were observed in the femoral heads of Ctnnb1<sup>Sp7ER</sup> mice (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>). Compared to <italic>Cre</italic>-negative littermates, the number of empty lacunae was increased in the femoral heads in Ctnnb1<sup>Col2ER</sup> mice (<xref ref-type="fig" rid="fig5">Figure 5E</xref>), but not changed in Ctnnb1<sup>Sp7ER</sup> mice (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). TUNEL staining revealed more apoptotic osteocytes in Ctnnb1<sup>Col2ER</sup> mice compared to <italic>Cre</italic>-negative littermates (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). All these findings indicate that loss of function of <italic>Ctnnb1</italic> in Col2<sup>+</sup> cells, but not in Sp7<sup>+</sup> cells, led to a GONFH-like phenotype in femoral head. Furthermore, decreased Runx2, ALP and increased PPAR-γ, CEBP/α protein expressions in Ctnnb1<sup>Col2ER</sup> mice (<xref ref-type="fig" rid="fig5">Figure 5G</xref>) revealed that this GONFH-like phenotype was caused by imbalance of osteogenic/adipogenic differentiation of Col2<sup>+</sup> cells.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Deletion of <italic>Ctnnb1</italic> in Col2<sup>+</sup> cells leads to a glucocorticoid-induced osteonecrosis of the femoral head (GONFH)-like phenotype.</title><p>Femoral heads were harvested from 3-month-old Ctnnb1<sup>Col2ER</sup> mice and <italic>Cre-</italic>negative littermates with five continuous dosages of tamoxifen (TM) injections (1 mg/10 g body weight) at the age of 2 wk. (<bold>A</bold>) Gross anatomy analysis of femoral heads in Ctnnb1<sup>Col2ER</sup> mice and <italic>Cre-</italic>negative littermates. (<bold>B</bold>) Representative μCT images and quantitative analysis of BV/TV, Tb.N, Tb.Th, and Tb.Sp in the femoral heads of Ctnnb1<sup>Col2ER</sup> mice. (<bold>C</bold>) Alcian Blue Hematoxylin (ABH) staining of femoral heads in Ctnnb1<sup>Col2ER</sup> mice. (a–d) High-magnification images of representative subchondral bone region; black triangle arrowheads: fat droplets; black arrows: empty lacunae of osteocytes. (<bold>D</bold>) Histomorphological quantitative analysis of trabecular bone area and fat droplet area in the femoral heads of Ctnnb1<sup>Col2ER</sup> mice. (<bold>E</bold>) Histomorphological quantitative analysis of empty lacunae rate in the femoral heads of Ctnnb1<sup>Col2ER</sup> mice. (<bold>F</bold>) TUNEL staining of osteocytes in the femoral heads of Ctnnb1<sup>Col2ER</sup> mice. (<bold>G</bold>) Immunohistochemistry (IHC) staining and quantitative analysis of Runx2, ALP, PPAR-γ, and CEBP/α in the femoral heads of Ctnnb1<sup>Col2ER</sup> mice.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig5-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92469-fig5-v1.tif"/></fig><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Loss of function of <italic>Ctnnb1</italic> in Sp7<sup>+</sup> cells causes bone loss in the femoral heads.</title><p>Femoral heads were harvested from 3-month-old Ctnnb1<sup>Sp7ER</sup> mice and <italic>Cre-</italic>negative littermates with five continuous dosages of tamoxifen (TM) injections (1 mg/10 g body weight) at the age of 2 wk. (<bold>A</bold>) Gross anatomy analysis of femoral heads in Ctnnb1<sup>Sp7ER</sup> mice and <italic>Cre-</italic>negative littermates. (<bold>B</bold>) μCT images and quantitative analysis of BV/TV, Tb.N, Tb.Th, and Tb.Sp in the femoral heads of Ctnnb1<sup>Sp7ER</sup> mice. (<bold>C</bold>) Alcian Blue Hematoxylin (ABH) staining of femoral heads in Ctnnb1<sup>Sp7ER</sup> mice. (<bold>D</bold>) Histomorphological quantitative analysis of trabecular bone area and fat droplet area in the femoral heads of Ctnnb1<sup>Sp7ER</sup> mice. (<bold>E</bold>) Histomorphological quantitative analysis of empty lacunae rate in the femoral heads of Ctnnb1<sup>Sp7ER</sup> mice.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig6-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92469-fig6-v1.tif"/></fig></sec><sec id="s2-5"><title>Older Ctnnb1<sup>Col2ER</sup> mice display subchondral bone destruction and collapse tendency in the femoral heads</title><p>Femoral head collapse occurs at the end stage of GONFH and represents a poor joint function (<xref ref-type="bibr" rid="bib16">Hines et al., 2021</xref>). To determine the occurrence of femoral head collapse, we further analyzed 6-month-old Ctnnb1<sup>Col2ER</sup> mice. Gross appearance showed that older Ctnnb1<sup>Col2ER</sup> mice lost smooth and regular outline on the femoral heads compared to <italic>Cre</italic>-negative littermates and 3-month-old Ctnnb1<sup>Col2ER</sup> mice (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). μCT images showed severe bone loss (<xref ref-type="fig" rid="fig7">Figure 7B and C</xref>), subchondral bone destruction (<xref ref-type="fig" rid="fig7">Figure 7B</xref>, yellow arrows), local collapse (<xref ref-type="fig" rid="fig7">Figure 7B</xref>, red arrows), and integral deformity (<xref ref-type="fig" rid="fig7">Figure 7B</xref>, red dotted lines) in the femoral heads of older Ctnnb1<sup>Col2ER</sup> mice. μCT quantitative analysis confirmed a significant increase of subchondral bone defect area on the femoral head surface in older Ctnnb1<sup>Col2ER</sup> mice (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Besides these early necrotic changes including sparse bone trabeculae, accumulated fat droplets (<xref ref-type="fig" rid="fig7">Figure 7E</xref>, black triangles), and increased empty lacunae of osteoctyes (<xref ref-type="fig" rid="fig7">Figure 7E</xref>, black arrows, <xref ref-type="fig" rid="fig7">Figure 7F</xref>), ABH staining also showed subchondral bone destruction (<xref ref-type="fig" rid="fig7">Figure 7</xref>, yellow arrows), and femoral head collapse or deformity (<xref ref-type="fig" rid="fig7">Figure 7E</xref>, red arrows and red dotted lines) in older Ctnnb1<sup>Col2ER</sup> mice. Compared to <italic>Cre</italic>-negative littermates, the older Ctnnb1<sup>Col2ER</sup> mice presented a decrease of loading-bearing stiffness, indicating a poor biomechanical support of the femoral heads (<xref ref-type="fig" rid="fig7">Figure 7G</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Older Ctnnb1<sup>Col2ER</sup> mice display subchondral bone destruction and collapse tendency in femoral heads.</title><p>Femoral heads were harvested from 6-month-old Ctnnb1<sup>Col2ER</sup> mice and <italic>Cre-</italic>negative littermates with five continuous dosages of tamoxifen (TM) injections (1 mg/10 g body weight) at the age of 2 wk. (<bold>A</bold>) Gross anatomy analysis of femoral heads in 6-month-old Ctnnb1<sup>Col2ER</sup> mice. (<bold>B</bold>) Representative μCT images of femoral heads in 6-month-old Ctnnb1<sup>Col2ER</sup> mice. Red dotted lines: integral deformity. Red arrows: local collapse. Yellow arrows: subchondral bone destruction. (<bold>C</bold>) Quantitative analysis of BV/TV in the femoral heads in 6-month-old Ctnnb1<sup>Col2ER</sup> mice. (<bold>D</bold>) Quantitative analysis of subchondral bone defect area on the femoral head surface in older Ctnnb1<sup>Col2ER</sup> mice. (<bold>E</bold>) Alcian Blue Hematoxylin (ABH) staining of femoral heads in 6-month-old Ctnnb1<sup>Col2ER</sup> mice. (a–c) High-magnification images of representative subchondral bone region. Red dotted lines: integral deformity. Red arrows: local collapse. Black arrows: empty lacunae of osteoctyes. Black triangles: fat droplets. (<bold>F</bold>) Histomorphological quantitative analysis of empty lacunae rate. (<bold>G</bold>) Loading-bearing stiffness of the femoral heads in 6-month-old Ctnnb1<sup>Col2ER</sup> mice.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig7">Figure 7</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig7-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92469-fig7-v1.tif"/></fig></sec><sec id="s2-6"><title>Wnt agonist 1 could not alleviate GONFH-like phenotype in Ctnnb1<sup>Col2ER</sup> mice</title><p>Regarding the therapeutic effects of Wnt agonist 1 on rat GONFH, we further determined whether it could alleviate the GONFH-like phenotype in Ctnnb1<sup>Col2ER</sup> mice. After induction with TM, Ctnnb1<sup>Col2ER</sup> mice were immediately injected with Wnt agonist 1 three times once a week until they were analyzed at the age of 3 mo. However, μCT images and quantitative analysis of BV/TV, Tb.N, Tb.Th, and Tb.Sp showed that severe bone loss was not restored in Ctnnb1<sup>Col2ER</sup> mice by treating with Wnt agonist 1 (<xref ref-type="fig" rid="fig8">Figure 8A and B</xref>). Accumulated fat droplets, sparse trabeculae, and empty lacunae still existed in the femoral heads of Wnt agonist 1-treated Ctnnb1<sup>Col2ER</sup> mice (<xref ref-type="fig" rid="fig8">Figure 8C–E</xref>). IHC staining showed no change of decreased ALP and increased FABP4 in the femoral heads of Ctnnb1<sup>Col2ER</sup> mice after Wnt agonist 1 treatment (<xref ref-type="fig" rid="fig8">Figure 8F and G</xref>). These findings indicate that Wnt agonist 1 could not restore the imbalanced osteogenic/adipogenic differentiation of Col2<sup>+</sup> cells in Ctnnb1<sup>Col2ER</sup> mice.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Systemic injection of Wnt agonist 1 cannot alleviate the glucocorticoid-induced osteonecrosis of the femoral head (GONFH)-like phenotype in Ctnnb1<sup>Col2ER</sup> mice.</title><p>Ctnnb1<sup>Col2ER</sup> mice with five continuous dosages of tamoxifen (TM) injections (1 mg/10 g body weight) were treated with Wnt agonist 1 three times once a week until sacrifice at the age of 3 mo. (<bold>A</bold>) Representative μCT images of femoral heads in Wnt agonist 1-treated Ctnnb1<sup>Col2ER</sup> mice. (<bold>B</bold>) Quantitative analysis of BV/TV, Tb.N, Tb.Th, and Tb.Sp in the femoral heads of Wnt agonist 1-treated Ctnnb1<sup>Col2ER</sup> mice. (<bold>C</bold>) Alcian Blue Hematoxylin (ABH) staining of the femoral heads in Wnt agonist 1-treated Ctnnb1<sup>Col2ER</sup> mice. (a, b) High-magnification images of subchondral bone region. Black triangles: fat droplets. (<bold>D</bold>) Histomorphological quantitative analysis of trabecular bone area and fat droplet area in the femoral heads of Wnt agonist 1-treated Ctnnb1<sup>Col2ER</sup> mice. (<bold>E</bold>) Histomorphological quantitative analysis of empty lacunae rate in the femoral heads of Wnt agonist 1-treated Ctnnb1<sup>Col2ER</sup> mice. (<bold>F, G</bold>) Immunohistochemistry (IHC) staining and quantitative analysis of ALP and FABP4 in the femoral heads of Wnt agonist 1-treated Ctnnb1<sup>Col2ER</sup> mice.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig8">Figure 8</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92469-fig8-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92469-fig8-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Despite being well known that glucocorticoids are the certain etiology of GONFH, its pathogenesis remains largely unknown. Current evidence, including reduced osteogenic differentiation ability of BMSCs from GONFH patients and clinical therapeutical effects of BMSCs transplantation, indicates that GONFH could result from abnormal differentiation of BMSCs (<xref ref-type="bibr" rid="bib17">Houdek et al., 2016</xref>; <xref ref-type="bibr" rid="bib47">Wang et al., 2019b</xref>; <xref ref-type="bibr" rid="bib38">Tabatabaee et al., 2015</xref>; <xref ref-type="bibr" rid="bib11">Gangji and Hauzeur, 2005</xref>). Glucocorticoid-induced animal models are commonly used for GONFH research, and several studies have revealed that direct BMSCs modifications with miRNA (<xref ref-type="bibr" rid="bib2">Cao et al., 2021</xref>; <xref ref-type="bibr" rid="bib13">Gu et al., 2016</xref>), lncRNA (<xref ref-type="bibr" rid="bib45">Wang et al., 2018c</xref>; <xref ref-type="bibr" rid="bib58">Xu et al., 2022</xref>), and circRNA (<xref ref-type="bibr" rid="bib5">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="bib54">Xiang et al., 2020</xref>) or microenvironment interventions by injecting platelet-rich plasma (<xref ref-type="bibr" rid="bib57">Xu et al., 2021</xref>; <xref ref-type="bibr" rid="bib49">Wang et al., 2022</xref>), exosome (<xref ref-type="bibr" rid="bib24">Li et al., 2020</xref>; <xref ref-type="bibr" rid="bib9">Fang et al., 2019</xref>) and growth factors (<xref ref-type="bibr" rid="bib14">Guzman et al., 2021</xref>; <xref ref-type="bibr" rid="bib32">Rackwitz et al., 2012</xref>) could promote osteogenic differentiation of BMSCs and exhibit anti-GONFH effects in animals. In the present study, we found severe trabecular bone loss and massive fat droplet accumulation in the necrotic femoral heads of GONFH patients and glucocorticoid-induced GONFH rats, confirming increased adipogenesis and decreased osteogenesis in GONFH pathogenesis. Dex inhibited osteogenic differentiation of rat BMSCs and promoted their adipogenic differentiation, revealing that this abnormal osteogenesis and adipogenesis in GONFH rats were caused by the imbalance in osteogenic/adipogenic differentiation of BMSCs. As β-catenin plays an important role in BMSCs differentiation, we then analyzed its role in GONFH pathogenesis. The results showed a significant inhibition of β-catenin signaling in the necrotic femoral heads of GONFH patients and glucocorticoid-induced GONFH rats, while Wnt agonist 1 attenuated accumulated fat droplets and sparse trabeculae in GONFH rats by activation of β-catenin signaling. The subsequent cellular experiments revealed that β-catenin activation restored the imbalance of osteogenic/adipogenic differentiation of BMSCs caused by long-term exposure to Dex. Overall, these findings indicate that β-catenin inhibition-induced imbalanced osteogenic/adipogenic differentiation of BMSCs contributed to GONFH.</p><p>BMSCs are a group of heterogeneous cells, and the majority are derived from skeletal progenitors (<xref ref-type="bibr" rid="bib12">Gao et al., 2021</xref>). It has reported that both Col2<sup>+</sup> progenitors and Sp7<sup>+</sup> progenitors provide a large proportion of BMSCs (<xref ref-type="bibr" rid="bib29">Ono et al., 2014</xref>). Adult transgenic mice with conditional deletion of <italic>Ctnnb1</italic> in Col2<sup>+</sup> cells, but not Sp7<sup>+</sup> cells, displayed a GONFH-like phenotype. Extensive trabecular bone was replaced by fat droplets in the femoral head (especially in the subchondral bone region) of Ctnnb1<sup>Col2ER</sup> mice compared to Ctnnb1<sup>Sp7ER</sup> mice. Cell fate mapping revealed an apparent difference in the distributions of Sp7<sup>+</sup> cells and Col2<sup>+</sup> cells in the femoral head when mice were induced at 2 weeks old. Besides the similar parts with Sp7<sup>+</sup> cells (osteoblasts, osteocytes, and stromal cells underneath growth plate), Col2<sup>+</sup> cells are also largely expressed in the chondrocytes of articular cartilage, secondary ossification center, and growth plate. Whether these Col2<sup>+</sup> chondrocytes in secondary ossification center and growth plate caused this GONFH-like phenotype, the osteogenic commitment of these Col2<sup>+</sup> chondrocytes has been reported (<xref ref-type="bibr" rid="bib34">Shu et al., 2021</xref>; <xref ref-type="bibr" rid="bib25">Li et al., 2022</xref>). At the age of 3 mo, Col2<sup>+</sup> chondrocytes in the secondary ossification center and growth plate were almost replaced by Col2<sup>+</sup> osteoblasts, osteocytes, and stromal cells, while GONFH-like phenotype, including fat droplet accumulation and sparse bone trabeculae, could be still observed in 6-month-old Ctnnb1<sup>Col2ER</sup> mice, indicating that not only Col2<sup>+</sup> chondrocytes but all Col2<sup>+</sup> cells in different cellular morphology were involved in this GONFH-like phenotype. Nine months of lineage trace further revealed that Col2<sup>+</sup> cells had self-renew ability and could continuously produce osteoblasts. The decreased ALP, Runx2 and increased CEBP/α and PPAR-γ in Ctnnb1<sup>Col2ER</sup> mice revealed that inhibition of β-catenin shifted the commitment of Col2<sup>+</sup> cells from osteoblasts to adipocytes, which should be responsible for this GONFH-like phenotype.</p><p>Femoral head collapse is the key feature of late-stage GONFH and is disastrous to hip joint (<xref ref-type="bibr" rid="bib46">Wang et al., 2019a</xref>). Although it has been well recognized that poor mechanical support caused structural collapse of necrotic femoral head (<xref ref-type="bibr" rid="bib8">Fan et al., 2011</xref>), its detailed pathogenesis is poorly understood due to the lack of ideal animal models. Glucocorticoid-induced bipedal and quadrupedal animal models only exhibit the early necrotic changes of GONFH (<xref ref-type="bibr" rid="bib56">Xu et al., 2018</xref>), without structure collapse of femoral head in MPS-induced rats. Other models using chemical or physical approaches all failed to mimic full-range osteonecrosis of GONFH in humans (<xref ref-type="bibr" rid="bib48">Wang et al., 2021</xref>). Importantly, we found that femoral head collapse occurred spontaneously in older Ctnnb1<sup>Col2ER</sup> mice. Besides the early necrotic changes, including trabecular bone loss, empty lacunae, and fat droplet accumulation, extensive subchondral bone destruction was identified in 6-month-old Ctnnb1<sup>Col2ER</sup> mice. Previous studies have revealed that strong trabeculae and integrated subchondral bone are critical to maintaining femoral head morphology (<xref ref-type="bibr" rid="bib19">Kawano et al., 2020</xref>; <xref ref-type="bibr" rid="bib28">Motomura et al., 2011</xref>). A significant decrease of loading-bearing stiffness confirmed a poor biomechanical support in 6-month-old Ctnnb1<sup>Col2ER</sup> mice. Therefore, it could be concluded that β-catenin inhibition-induced imbalanced osteogenic/adipogenic differentiation of Col2<sup>+</sup> cells caused a poor biomechanical support (manifesting with sparse trabeculae and subchondral bone destruction), eventually leading to femoral head collapse in Ctnnb1<sup>Col2ER</sup> mice.</p><p>Osteocytes are the bone cells with the longest life, up to decades within their mineralized environment (<xref ref-type="bibr" rid="bib7">Dallas et al., 2013</xref>; <xref ref-type="bibr" rid="bib1">Bonewald, 2011</xref>). However, numerous empty lacunae of osteocyte were observed in the necrotic femoral head of GONFH patients and glucocorticoid-induced rats. Glucocorticoids are known to induce cell apoptosis (<xref ref-type="bibr" rid="bib50">Weinstein, 2012</xref>), and TUNEL staining confirmed increased osteocyte apoptosis in the human and rat necrotic femoral heads, leaving behind these empty lacunae. The importance of β-catenin in the regulation of apoptosis is well established in the skeletal system (<xref ref-type="bibr" rid="bib18">Jähn et al., 2012</xref>; <xref ref-type="bibr" rid="bib20">Kitase et al., 2010</xref>). Consistently, the expression of β-catenin was significantly decreased in the human and rat necrotic femoral heads. Moreover, we found that genetic deletion of <italic>Ctnnb1</italic> in Col2<sup>+</sup> cells spontaneously caused osteocyte apoptosis in mice and activation of β-catenin by systematically injecting Wnt agonist 1 alleviated osteocyte apoptosis in glucocorticoid-induced rats, which indicate that β-catenin inhibition-induced osteocyte apoptosis contributed to empty lacunae of GONFH.</p><p>There are some limitations to the present study. Firstly, Wnt agonist 1 is a cell-permeating activator of Wnt signaling that induces transcriptional activity dependent on β-catenin (<xref ref-type="bibr" rid="bib26">Lim et al., 2008</xref>; <xref ref-type="bibr" rid="bib21">Kuncewitch et al., 2015</xref>). Thus, Wnt agonist 1 alleviated rat GONFH by activating β-catenin signaling, but could not rescue GONFH-like phenotype in Ctnnb1<sup>Col2ER</sup> mice. Nevertheless, it remains unclear how Wnt agonist 1 works to activate β-catenin signaling. Secondly, Ctnnb1<sup>Sp7ER</sup> mice presented few lipid droplets and empty lacunae but a significant decrease in bone mass in the femoral heads. Previous studies revealed that specific knockout of <italic>Ctnnb1</italic> in Sp7-expressing cells promotes osteoclast formation and activity (<xref ref-type="bibr" rid="bib62">Yu et al., 2018</xref>; <xref ref-type="bibr" rid="bib36">Song et al., 2022</xref>), while its exact mechanism of bone mass loss still needs to be verified. Thirdly, that bone damage caused a poor mechanical support is the key to femoral head collapse. Although it is well known that an extensive subchondral bone destruction finally led to femoral head collapse in 6-month-old Ctnnb1<sup>Col2ER</sup> mice, the detailed mechanism of why this subchondral bone destruction occurs with age is still unclear.</p><p>In summary, our studies revealed that β-catenin inhibition induces the imbalance in osteogenic/adipogenic differentiation of BMSCs and plays a crucial role in GONFH pathogenesis. We also provided a <italic>Col2</italic>-specific <italic>Ctnnb1</italic> knockout mouse model for the first time, which mimics full spectrum of osteonecrosis phenotype of GONFH.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Human specimen collection</title><p>Fifteen necrotic femoral head samples were collected from GONFH patients (ARCO grades III–IV) who received arthroplasty surgery. Ten non-necrotic femoral head samples were acquired from femoral neck fracture patients. Before the surgery, all patients signed the informed consent that their femoral head samples could be used for scientific research. All experiments with human specimens in the present study were approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University (2018KL-005). The information of patients is listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-2"><title>Animals and interventions</title><p>Thirty 2-month-old male SD rats were purchased from the Animal Laboratory Center of Zhejiang Chinese Medical University (Zhejiang, China, SCXK 2014-0004) and randomly divided into sham group, GONFH group, and treatment group (n = 10 per group). We adopted Zheng’s methods to establish a glucocorticoid-induced GONFH rat model (<xref ref-type="bibr" rid="bib71">Zheng et al., 2018</xref>). Firstly, rats in the GONFH group and treatment group received one injection of lipopolysaccharide (0.2 mg/kg body weight, Sigma, USA) by tail vein, followed by three continuous intraperitoneal injections of 100 mg/kg body MPS (Pfizer, USA). In the subsequent 6 wk, MPS was intraperitoneally injected at the dosage of 40 mg/kg body weight three times every week. Rats in the treatment group were intravenously injected with Wnt agonist 1 (5 mg/kg body weight, Selleck, USA) at a synchronous frequency with MPS.</p><p><italic>Col2a1-CreER<sup>T2</sup></italic> mice, <italic>Ctnnb1<sup>flox/flox</sup></italic> mice, <italic>Sp7-CreER<sup>T2</sup></italic> mice, and <italic>Rosa26-LSL-tdTomato</italic> mice were obtained from Jackson Laboratory. To map cell fate of Col2<sup>+</sup> cells and Sp7<sup>+</sup> cells in the femoral head, <italic>Col2a1-CreER<sup>T2</sup>;Rosa26-LSL-tdTomato</italic> (Tomato<sup>Col2ER</sup>) mice and <italic>Sp7-CreER<sup>T2</sup>;Rosa26-LSL-tdTomato</italic> (Tomato<sup>Sp7ER</sup>) mice were induced by intraperitoneally injecting with tamoxifen (TM, 1 mg/10 g body weight/day, diluted in corn oil) for five consecutive days at the age of 2 or 4 wk, and traced as long as 9 months old. Mouse genotyping sequences are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. To further investigate the role of β-catenin in GONFH pathogenesis, <italic>Col2a1-CreER<sup>T2</sup>;Ctnnb1<sup>flox/flox</sup></italic> (Ctnnb1<sup>Col2ER</sup>) mice and <italic>Sp7-CreER<sup>T2</sup>;Ctnnb1<sup>flox/flox</sup></italic> (Ctnnb1<sup>Sp7ER</sup>) mice were generated and induced with five continuous injections of TM. After induction, Wnt agonist 1 (5 mg/kg body weight) was intravenously injected into Ctnnb1<sup>Col2ER</sup> mice three times every week until they were sacrificed at the age of 3 mo. All animal experiments were approved by the Animal Ethics Committee of Zhejiang Chinese Medical University (no. 20190401-10).</p></sec><sec id="s4-3"><title>Stereomicroscopy observation and biomechanical testing</title><p>Femoral head tissues harvested from human patients, glucocorticoid-induced GONFH rats, Ctnnb1<sup>Col2ER</sup> mice, and Ctnnb1<sup>Sp7ER</sup> mice were viewed under a stereomicroscope (model C-DSD230, Nikon, Japan) to assess their appearance characteristics. The fresh femoral head tissues were placed on the test platform of a biomechanical testing machine (EnduraTec TestBench system, Minnetonka, MN). The axial compression load was applied at a speed of 0.5 mm/min until femoral head deformation. The loading-bearing stiffness of femoral head was calculated by testing software.</p></sec><sec id="s4-4"><title>μCT analysis</title><p>Femoral head samples were scanned with a micro-computed tomography (μCT, Skyscan 1176, Bruker μCT, Kontich, Belgium) at a resolution of 9 μm. Three-dimensional (3D) structure was reconstructed using NRecon Software v1.6 as described previously (<xref ref-type="bibr" rid="bib51">Xia et al., 2019</xref>). The region of interest in the subchondral bone was selected for morphometric analysis, including bone volume fraction (BV/TV, %), average trabecular thickness (Tb.Th, mm), average trabecular number (Tb.N, 1/mm), average trabecular separation (Tb.Sp, mm) and subchondral bone defect area (%).</p></sec><sec id="s4-5"><title>Histology, immunohistochemistry, and histomorphometry</title><p>Femoral head tissues were processed into 3-μm-thick paraffin section or 10-μm-thick frozen section as described previously (<xref ref-type="bibr" rid="bib52">Xia et al., 2020a</xref>). After deparaffinage and rehydration, sections were stained with ABH for 1 hr and then Orange G for 1 min for histological analysis. After ABH/Orange G staining, bone tissue presented yellow color and cartilage was blue. The trabecular bone area (%), fat droplet area (%), and empty lacuna rate (%) were measured using OsteoMetrics software (Decatur, GA). The frozen sections were performed with 4',6-diamidino-2-phenylindole (DAPI) staining and hematoxylin and eosin (H&amp;E) staining for evaluating <italic>Cre</italic>-recombination efficiency.</p><p>IHC assay was performed on the paraffin sections according to the previously established procedures (<xref ref-type="bibr" rid="bib53">Xia et al., 2020b</xref>). Briefly, sections were immersed into 0.01 M citrate buffer (Solarbio, Beijing, China) at 60°C for 4 hr to repair antigen. After washing with phosphate buffer (PBS) three times, the sections were incubated with primary antibodies including β-catenin (diluted 1:500, abcam, ab32572, UK), Runx2 (diluted 1:200, Abcam, ab76956, UK), alkaline phosphatase (ALP, diluted 1:200, ARIGO, ARG57422, CN), osteocalcin (OCN; diluted 1:200, Takara, UK), PPAR-γ (diluted 1:300, Abcam,ab19481, UK), CEBP/α (diluted 1:400, Huabio, EM1710-02, CA), and fatty acid-binding protein (FABP4, diluted 1:200, abcam, ab92501, UK) overnight at 4°C. After incubation with secondary antibodies for 30 min at room temperature, tissue sections were stained with diaminobenzidine (DAB) solution to detect positive staining and hematoxylin for counterstaining. Mean density (IOD/area) as the parameter of immunohistochemical quantitative analysis was evaluated using Image-Pro Plus software (Media Cybernetics, Silver Spring, USA).</p></sec><sec id="s4-6"><title>Rat BMSC isolation and identification</title><p>BMSC isolation was conducted as previously described (<xref ref-type="bibr" rid="bib72">Zhu et al., 2020</xref>). Briefly, bone marrow cells were isolated from the proximal femur of 4-week-old SD rats. After centrifugation at 200 × <italic>g</italic> for 10 min, cells were resuspended with α-MEM (Gibco, Grand Island, NY) containing 10% fetal bovine serum (FBS, Gibco). By changing the medium 48 hr later, non-adherent cells were removed and the primary BMSCs were harvested. At 100% confluence, primary cultures were detached using trypsin and subcultured at 8 × 10<sup>3</sup> cells/cm<sup>2</sup>. A total of 50 μL third passage (P3) BMSC suspension (4 × 10<sup>6</sup>/mL) were mixed with 5 μL of rat CD90-APC, rat anti-CD29-BV421, rat anti-CD45-FITC, or rat CD11b-PE (BD Pharmingen, Franklin Lakes, NJ) in each flow cytometry tube. After incubation at room temperature for 30 min followed by twice washes of a staining buffer, the cells were resuspended with 500 μL staining buffer for flow cytometry analysis.</p></sec><sec id="s4-7"><title>Rat BMSC intervention and staining</title><p>To investigate the role of glucocorticoids on BMSC differentiation, P3 BMSCs were treated with gradient concentrations of Dex (0, 10, 10<sup>2</sup>, 10<sup>3</sup>, 10<sup>4</sup>, 10<sup>5</sup> nM) (Selleck, Shanghai, China) with or without SKL2001 (an agonist of β-catenin) (Selleck) for 72 hr. For oil red O staining, BMSCs were treated with adipogenic medium (α-MEM containing 10% FBS, 0.25 mM methylisobutylxanthine, 5 μg/mL insulin, and 50 μM indomethacin) for 72 hr followed by 5 μg/mL insulin alone for an additional 48 hr. After being fixed in 4% paraformaldehyde for 10 min, BMSCs were stained in 60% saturated oil red O solution for 5 min. For ALP staining, BMSCs were treated with osteogenic medium (α-MEM containing 10% FBS, 50 μg/mL ascorbic acid, and 5 mM β-glycerophosphate) for 14 d, fixed in 4% paraformaldehyde for 10 min, and stained with ALP staining kit (Thermo Fisher Scientific, Rockford, IL) for 15 min.</p></sec><sec id="s4-8"><title>Western blot analysis</title><p>According to the appearance and CT images, two pieces (about 2 * 2 * 2 cm<sup>3</sup>) of necrotic tissues were cut from each human necrotic femoral head and the corresponding region from human fractured femoral head. These necrotic and non-necrotic tissues were mixed and ground into powder after being processed by liquid nitrogen, respectively. Tissue powder and rat P3 BMSCs were lysed by protein extraction reagent, and the liquid supernatant containing total protein was obtained through centrifuging at 12,000 × <italic>g</italic> for 20 min. Then, proteins were separated by SDS-PAGE and transferred onto nitrocellulose membranes. The membranes were incubated overnight with primary antibodies including β-catenin (CST, 9582, USA), Runx2 (abcam, ab236639, UK), Osterix (huabio, ER1914-47, CA), ALP (arigo, ARG57422, CA), PPAR-γ (arigo, ARG55241, CA), and CEBP/α (CST, 8178s, USA) at a 1:1000 dilution. Next, the membranes were incubated with appropriate horseradish peroxidase-conjugated secondary antibodies at 37°C for 1 hr. The immune complexes were detected using a chemiluminescence kit and visualized via the ChemiDoc XRS Gel documentation system (Bio-Rad, CA). The gray intensity was measured using the software Quantity One (Bio-Rad).</p></sec><sec id="s4-9"><title>Statistical analysis</title><p>All data were presented as mean ± standard deviation (SD). Statistical analyses, including unpaired Student’s <italic>t</italic>-test (two groups) and one-way ANOVA followed by Tukey’s test (multiple groups), were performed with the SPSS 22.0 software. *p&lt;0.05, **p&lt;0.01 were considered statistically significant.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Funding acquisition, Validation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Software, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Software, Validation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation, Software</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con6"><p>Visualization, Methodology</p></fn><fn fn-type="con" id="con7"><p>Software, Methodology</p></fn><fn fn-type="con" id="con8"><p>Resources, Software, Funding acquisition, Methodology</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Funding acquisition</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Data curation</p></fn><fn fn-type="con" id="con11"><p>Resources, Funding acquisition</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Validation, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Resources, Software, Supervision, Validation, Project administration</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All experiments with human specimens were approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University (2018KL-005). Before the surgery, all patients signed the informed consent that their femoral head samples could be used for scientific research.</p></fn><fn fn-type="other"><p>All animal experiments were approved by the Animal Ethics Committee of Zhejiang Chinese Medical University (No. 20190401-10).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>The information of patients who provided femoral head samples.</title></caption><media xlink:href="elife-92469-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>The primer sequences of mouse genotype.</title></caption><media xlink:href="elife-92469-supp2-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-92469-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files.</p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by the Chinese National Natural Science Foundation (grants nos. 82074469, 82104885, 82250710174 and 82161160342), Natural Science Foundation of Zhejiang Province (grants nos. LQ22H270001, LY21H270008, and LR23H270001), Ningbo medical key discipline (grant no. 2022-B01), and Ningbo Top Medical and Health Program (grant no. 2022020102).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonewald</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The amazing osteocyte</article-title><source>Journal of Bone and Mineral Research</source><volume>26</volume><fpage>229</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1002/jbmr.320</pub-id><pub-id pub-id-type="pmid">21254230</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Reciprocal effect of microRNA-224 on osteogenesis and adipogenesis in steroid-induced osteonecrosis of the femoral head</article-title><source>Bone</source><volume>145</volume><elocation-id>115844</elocation-id><pub-id pub-id-type="doi">10.1016/j.bone.2021.115844</pub-id><pub-id pub-id-type="pmid">33453444</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Greenspan</surname><given-names>A</given-names></name><name><surname>Gershwin</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Osteonecrosis: current perspectives on pathogenesis and treatment</article-title><source>Seminars in Arthritis and Rheumatism</source><volume>23</volume><fpage>47</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/s0049-0172(05)80026-5</pub-id><pub-id pub-id-type="pmid">8235665</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X-J</given-names></name><name><surname>Shen</surname><given-names>Y-S</given-names></name><name><surname>He</surname><given-names>M-C</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Pang</surname><given-names>F-X</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>Q-S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Polydatin promotes the osteogenic differentiation of human bone mesenchymal stem cells by activating the BMP2-Wnt/β-catenin signaling pathway</article-title><source>Biomedicine &amp; Pharmacotherapy</source><volume>112</volume><elocation-id>108746</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2019.108746</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Circular RNA CDR1as promotes adipogenic and suppresses osteogenic differentiation of BMSCs in steroid-induced osteonecrosis of the femoral head</article-title><source>Bone</source><volume>133</volume><elocation-id>115258</elocation-id><pub-id pub-id-type="doi">10.1016/j.bone.2020.115258</pub-id><pub-id pub-id-type="pmid">32018039</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C-Y</given-names></name><name><surname>Rao</surname><given-names>S-S</given-names></name><name><surname>Yue</surname><given-names>T</given-names></name><name><surname>Tan</surname><given-names>Y-J</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>L-J</given-names></name><name><surname>Luo</surname><given-names>M-J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y-Y</given-names></name><name><surname>Hong</surname><given-names>C-G</given-names></name><name><surname>Qian</surname><given-names>Y-X</given-names></name><name><surname>He</surname><given-names>Z-H</given-names></name><name><surname>Liu</surname><given-names>J-H</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>F-Y</given-names></name><name><surname>Tang</surname><given-names>S-Y</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis</article-title><source>Science Advances</source><volume>8</volume><elocation-id>eabg8335</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abg8335</pub-id><pub-id pub-id-type="pmid">35417243</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dallas</surname><given-names>SL</given-names></name><name><surname>Prideaux</surname><given-names>M</given-names></name><name><surname>Bonewald</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The osteocyte: an endocrine cell... and more</article-title><source>Endocrine Reviews</source><volume>34</volume><fpage>658</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1210/er.2012-1026</pub-id><pub-id pub-id-type="pmid">23612223</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>M</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Experimental animal models of osteonecrosis</article-title><source>Rheumatology International</source><volume>31</volume><fpage>983</fpage><lpage>994</lpage><pub-id pub-id-type="doi">10.1007/s00296-011-1819-9</pub-id><pub-id pub-id-type="pmid">21340568</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Osteogenic effect of bone marrow mesenchymal stem cell-derived exosomes on steroid-induced osteonecrosis of the femoral head</article-title><source>Drug Design, Development and Therapy</source><volume>13</volume><fpage>45</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S178698</pub-id><pub-id pub-id-type="pmid">30587927</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Xiang</surname><given-names>Q</given-names></name><name><surname>Jia</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>T</given-names></name><name><surname>Liao</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>CircHGF suppressed cell proliferation and osteogenic differentiation of BMSCs in ONFH via inhibiting miR-25-3p binding to SMAD7</article-title><source>Molecular Therapy. Nucleic Acids</source><volume>28</volume><fpage>99</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.omtn.2022.02.017</pub-id><pub-id pub-id-type="pmid">35402073</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangji</surname><given-names>V</given-names></name><name><surname>Hauzeur</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique</article-title><source>The Journal of Bone and Joint Surgery. American Volume</source><volume>87 Suppl 1</volume><fpage>106</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.2106/JBJS.D.02662</pub-id><pub-id pub-id-type="pmid">15743852</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Jing</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Bone Marrow Mesenchymal Stromal Cells: Identification, Classification, and Differentiation</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>787118</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.787118</pub-id><pub-id pub-id-type="pmid">35047499</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Guan</surname><given-names>H</given-names></name><name><surname>Song</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>miR-27a attenuates adipogenesis and promotes osteogenesis in steroid-induced rat BMSCs by targeting PPARγ and GREM1</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>38491</elocation-id><pub-id pub-id-type="doi">10.1038/srep38491</pub-id><pub-id pub-id-type="pmid">27910957</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>RA</given-names></name><name><surname>Maruyama</surname><given-names>M</given-names></name><name><surname>Moeinzadeh</surname><given-names>S</given-names></name><name><surname>Lui</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Storaci</surname><given-names>HW</given-names></name><name><surname>Tam</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>EE</given-names></name><name><surname>Utsunomiya</surname><given-names>T</given-names></name><name><surname>Rhee</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>Q</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>YP</given-names></name><name><surname>Goodman</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The effect of genetically modified platelet-derived growth factor-BB over-expressing mesenchymal stromal cells during core decompression for steroid-associated osteonecrosis of the femoral head in rabbits</article-title><source>Stem Cell Research &amp; Therapy</source><volume>12</volume><elocation-id>503</elocation-id><pub-id pub-id-type="doi">10.1186/s13287-021-02572-7</pub-id><pub-id pub-id-type="pmid">34526115</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Gong</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor</article-title><source>Stem Cell Research &amp; Therapy</source><volume>10</volume><elocation-id>377</elocation-id><pub-id pub-id-type="doi">10.1186/s13287-019-1498-0</pub-id><pub-id pub-id-type="pmid">31805987</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hines</surname><given-names>JT</given-names></name><name><surname>Jo</surname><given-names>WL</given-names></name><name><surname>Cui</surname><given-names>Q</given-names></name><name><surname>Mont</surname><given-names>MA</given-names></name><name><surname>Koo</surname><given-names>KH</given-names></name><name><surname>Cheng</surname><given-names>EY</given-names></name><name><surname>Goodman</surname><given-names>SB</given-names></name><name><surname>Ha</surname><given-names>YC</given-names></name><name><surname>Hernigou</surname><given-names>P</given-names></name><name><surname>Jones</surname><given-names>LC</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Sugano</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Drescher</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>TY</given-names></name><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Yoon</surname><given-names>BH</given-names></name><name><surname>Baek</surname><given-names>SH</given-names></name><name><surname>Ando</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment</article-title><source>Journal of Korean Medical Science</source><volume>36</volume><elocation-id>e177</elocation-id><pub-id pub-id-type="doi">10.3346/jkms.2021.36.e177</pub-id><pub-id pub-id-type="pmid">34155839</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houdek</surname><given-names>MT</given-names></name><name><surname>Wyles</surname><given-names>CC</given-names></name><name><surname>Packard</surname><given-names>BD</given-names></name><name><surname>Terzic</surname><given-names>A</given-names></name><name><surname>Behfar</surname><given-names>A</given-names></name><name><surname>Sierra</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Decreased osteogenic activity of mesenchymal stem cells in patients with corticosteroid-induced osteonecrosis of the femoral head</article-title><source>The Journal of Arthroplasty</source><volume>31</volume><fpage>893</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2015.08.017</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jähn</surname><given-names>K</given-names></name><name><surname>Lara-Castillo</surname><given-names>N</given-names></name><name><surname>Brotto</surname><given-names>L</given-names></name><name><surname>Mo</surname><given-names>CL</given-names></name><name><surname>Johnson</surname><given-names>ML</given-names></name><name><surname>Brotto</surname><given-names>M</given-names></name><name><surname>Bonewald</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin</article-title><source>European Cells &amp; Materials</source><volume>24</volume><fpage>197</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.22203/ecm.v024a14</pub-id><pub-id pub-id-type="pmid">22972510</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawano</surname><given-names>K</given-names></name><name><surname>Motomura</surname><given-names>G</given-names></name><name><surname>Ikemura</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>R</given-names></name><name><surname>Baba</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Nakashima</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Differences in the microarchitectural features of the lateral collapsed lesion between osteonecrosis and subchondral insufficiency fracture of the femoral head</article-title><source>Bone</source><volume>141</volume><elocation-id>115585</elocation-id><pub-id pub-id-type="doi">10.1016/j.bone.2020.115585</pub-id><pub-id pub-id-type="pmid">32795680</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitase</surname><given-names>Y</given-names></name><name><surname>Barragan</surname><given-names>L</given-names></name><name><surname>Qing</surname><given-names>H</given-names></name><name><surname>Kondoh</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>JX</given-names></name><name><surname>Johnson</surname><given-names>ML</given-names></name><name><surname>Bonewald</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways</article-title><source>Journal of Bone and Mineral Research</source><volume>25</volume><fpage>2657</fpage><lpage>2668</lpage><pub-id pub-id-type="doi">10.1002/jbmr.168</pub-id><pub-id pub-id-type="pmid">20578217</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuncewitch</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>WL</given-names></name><name><surname>Corbo</surname><given-names>L</given-names></name><name><surname>Khader</surname><given-names>A</given-names></name><name><surname>Nicastro</surname><given-names>J</given-names></name><name><surname>Coppa</surname><given-names>GF</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>WNT Agonist decreases tissue damage and improves renal function after ischemia-reperfusion</article-title><source>Shock</source><volume>43</volume><fpage>268</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1097/SHK.0000000000000293</pub-id><pub-id pub-id-type="pmid">25514428</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavernia</surname><given-names>CJ</given-names></name><name><surname>Sierra</surname><given-names>RJ</given-names></name><name><surname>Grieco</surname><given-names>FR</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Osteonecrosis of the femoral head</article-title><source>The Journal of the American Academy of Orthopaedic Surgeons</source><volume>7</volume><fpage>250</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.5435/00124635-199907000-00005</pub-id><pub-id pub-id-type="pmid">10434079</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Roh</surname><given-names>HL</given-names></name><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Jung</surname><given-names>JS</given-names></name><name><surname>Suh</surname><given-names>KT</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor</article-title><source>Journal of Orthopaedic Research</source><volume>24</volume><fpage>604</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1002/jor.20078</pub-id><pub-id pub-id-type="pmid">16514658</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>An</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Cao</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Bone marrow mesenchymal stem cell-derived exosomes promote plasminogen activator inhibitor 1 expression in vascular cells in the local microenvironment during rabbit osteonecrosis of the femoral head</article-title><source>Stem Cell Research &amp; Therapy</source><volume>11</volume><elocation-id>480</elocation-id><pub-id pub-id-type="doi">10.1186/s13287-020-01991-2</pub-id><pub-id pub-id-type="pmid">33176873</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>G</given-names></name><name><surname>Jing</surname><given-names>D</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Type II collagen-positive progenitors are important stem cells in controlling skeletal development and vascular formation</article-title><source>Bone Research</source><volume>10</volume><elocation-id>46</elocation-id><pub-id pub-id-type="doi">10.1038/s41413-022-00214-z</pub-id><pub-id pub-id-type="pmid">35739091</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>JC</given-names></name><name><surname>Kania</surname><given-names>KD</given-names></name><name><surname>Wijesuriya</surname><given-names>H</given-names></name><name><surname>Chawla</surname><given-names>S</given-names></name><name><surname>Sethi</surname><given-names>JK</given-names></name><name><surname>Pulaski</surname><given-names>L</given-names></name><name><surname>Romero</surname><given-names>IA</given-names></name><name><surname>Couraud</surname><given-names>PO</given-names></name><name><surname>Weksler</surname><given-names>BB</given-names></name><name><surname>Hladky</surname><given-names>SB</given-names></name><name><surname>Barrand</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells</article-title><source>Journal of Neurochemistry</source><volume>106</volume><fpage>1855</fpage><lpage>1865</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05537.x</pub-id><pub-id pub-id-type="pmid">18624906</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Strecker</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Kronenberg</surname><given-names>MS</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Rowe</surname><given-names>DW</given-names></name><name><surname>Maye</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Osterix-Cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e71318</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0071318</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motomura</surname><given-names>G</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Yamaguchi</surname><given-names>R</given-names></name><name><surname>Ikemura</surname><given-names>S</given-names></name><name><surname>Nakashima</surname><given-names>Y</given-names></name><name><surname>Mawatari</surname><given-names>T</given-names></name><name><surname>Iwamoto</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Morphological analysis of collapsed regions in osteonecrosis of the femoral head</article-title><source>The Journal of Bone and Joint Surgery. British Volume</source><volume>93</volume><fpage>184</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.93B225476</pub-id><pub-id pub-id-type="pmid">21282756</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname><given-names>N</given-names></name><name><surname>Ono</surname><given-names>W</given-names></name><name><surname>Nagasawa</surname><given-names>T</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones</article-title><source>Nature Cell Biology</source><volume>16</volume><fpage>1157</fpage><lpage>1167</lpage><pub-id pub-id-type="doi">10.1038/ncb3067</pub-id><pub-id pub-id-type="pmid">25419849</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petek</surname><given-names>D</given-names></name><name><surname>Hannouche</surname><given-names>D</given-names></name><name><surname>Suva</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment</article-title><source>EFORT Open Reviews</source><volume>4</volume><fpage>85</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1302/2058-5241.4.180036</pub-id><pub-id pub-id-type="pmid">30993010</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>D</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>W-C</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Griffith</surname><given-names>JF</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>JQ</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Xiao</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Xiong</surname><given-names>J</given-names></name><name><surname>Pei</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Pan</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>K-M</given-names></name><name><surname>Cheng</surname><given-names>C-Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Phytomolecule icaritin incorporated PLGA/TCP scaffold for steroid-associated osteonecrosis: Proof-of-concept for prevention of hip joint collapse in bipedal emus and mechanistic study in quadrupedal rabbits</article-title><source>Biomaterials</source><volume>59</volume><fpage>125</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2015.04.038</pub-id><pub-id pub-id-type="pmid">25968462</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rackwitz</surname><given-names>L</given-names></name><name><surname>Eden</surname><given-names>L</given-names></name><name><surname>Reppenhagen</surname><given-names>S</given-names></name><name><surname>Reichert</surname><given-names>JC</given-names></name><name><surname>Jakob</surname><given-names>F</given-names></name><name><surname>Walles</surname><given-names>H</given-names></name><name><surname>Pullig</surname><given-names>O</given-names></name><name><surname>Tuan</surname><given-names>RS</given-names></name><name><surname>Rudert</surname><given-names>M</given-names></name><name><surname>Nöth</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head</article-title><source>Stem Cell Research &amp; Therapy</source><volume>3</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/scrt98</pub-id><pub-id pub-id-type="pmid">22356811</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scaglione</surname><given-names>M</given-names></name><name><surname>Fabbri</surname><given-names>L</given-names></name><name><surname>Celli</surname><given-names>F</given-names></name><name><surname>Casella</surname><given-names>F</given-names></name><name><surname>Guido</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hip replacement in femoral head osteonecrosis: current concepts</article-title><source>Clinical Cases in Mineral and Bone Metabolism</source><volume>12</volume><fpage>51</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.11138/ccmbm/2015.12.3s.051</pub-id><pub-id pub-id-type="pmid">27134633</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>HS</given-names></name><name><surname>Liu</surname><given-names>YL</given-names></name><name><surname>Tang</surname><given-names>XT</given-names></name><name><surname>Zhang</surname><given-names>XS</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Zou</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>BO</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Tracing the skeletal progenitor transition during postnatal bone formation</article-title><source>Cell Stem Cell</source><volume>28</volume><fpage>2122</fpage><lpage>2136</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2021.08.010</pub-id><pub-id pub-id-type="pmid">34499868</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Ono</surname><given-names>N</given-names></name><name><surname>Bringhurst</surname><given-names>FR</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Loss of wnt/β-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes</article-title><source>Journal of Bone and Mineral Research</source><volume>27</volume><fpage>2344</fpage><lpage>2358</lpage><pub-id pub-id-type="doi">10.1002/jbmr.1694</pub-id><pub-id pub-id-type="pmid">22729939</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Postnatal deletion of β-catenin in preosteoblasts regulates global energy metabolism through increasing bone resorption and adipose tissue fibrosis</article-title><source>Bone</source><volume>156</volume><elocation-id>116320</elocation-id><pub-id pub-id-type="doi">10.1016/j.bone.2021.116320</pub-id><pub-id pub-id-type="pmid">34973494</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Geng</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Activation of cannabinoid receptor 2 alleviates glucocorticoid-induced osteonecrosis of femoral head with osteogenesis and maintenance of blood supply</article-title><source>Cell Death &amp; Disease</source><volume>12</volume><elocation-id>1035</elocation-id><pub-id pub-id-type="doi">10.1038/s41419-021-04313-3</pub-id><pub-id pub-id-type="pmid">34718335</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabatabaee</surname><given-names>RM</given-names></name><name><surname>Saberi</surname><given-names>S</given-names></name><name><surname>Parvizi</surname><given-names>J</given-names></name><name><surname>Mortazavi</surname><given-names>SMJ</given-names></name><name><surname>Farzan</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Combining concentrated autologous bone marrow stem cells injection with core decompression improves outcome for patients with early-stage osteonecrosis of the femoral head: A comparative study</article-title><source>The Journal of Arthroplasty</source><volume>30</volume><fpage>11</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2015.06.022</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>I</given-names></name><name><surname>Kouzmenko</surname><given-names>AP</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis</article-title><source>Nature Reviews. Rheumatology</source><volume>5</volume><fpage>442</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2009.137</pub-id><pub-id pub-id-type="pmid">19581903</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>SC</given-names></name><name><surname>Yuan</surname><given-names>T</given-names></name><name><surname>Rui</surname><given-names>BY</given-names></name><name><surname>Zhu</surname><given-names>ZZ</given-names></name><name><surname>Guo</surname><given-names>SC</given-names></name><name><surname>Zhang</surname><given-names>CQ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Exosomes derived from human platelet-rich plasma prevent apoptosis induced by glucocorticoid-associated endoplasmic reticulum stress in rat osteonecrosis of the femoral head via the Akt/Bad/Bcl-2 signal pathway</article-title><source>Theranostics</source><volume>7</volume><fpage>733</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.7150/thno.17450</pub-id><pub-id pub-id-type="pmid">28255363</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tencerova</surname><given-names>M</given-names></name><name><surname>Kassem</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Bone marrow-derived stromal cells: commitment and regulation of adipogenesis</article-title><source>Frontiers in Endocrinology</source><volume>7</volume><elocation-id>127</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2016.00127</pub-id><pub-id pub-id-type="pmid">27708616</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B-L</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>Z-C</given-names></name><name><surname>Lou</surname><given-names>J-N</given-names></name><name><surname>Zhang</surname><given-names>N-F</given-names></name><name><surname>Shi</surname><given-names>S-H</given-names></name><name><surname>Guo</surname><given-names>W-S</given-names></name><name><surname>Cheng</surname><given-names>L-M</given-names></name><name><surname>Ye</surname><given-names>L-Y</given-names></name><name><surname>Zhang</surname><given-names>W-J</given-names></name><name><surname>Li</surname><given-names>Z-R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Decreased proliferation of mesenchymal stem cells in corticosteroid-induced osteonecrosis of femoral head</article-title><source>Orthopedics</source><volume>31</volume><elocation-id>444</elocation-id><pub-id pub-id-type="doi">10.3928/01477447-20080501-33</pub-id><pub-id pub-id-type="pmid">19292322</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Meng</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018a</year><article-title>Analysis of early stage osteonecrosis of the human femoral head and the mechanism of femoral head collapse</article-title><source>International Journal of Biological Sciences</source><volume>14</volume><fpage>156</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.7150/ijbs.18334</pub-id><pub-id pub-id-type="pmid">29483834</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018b</year><article-title>The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature</article-title><source>Gene</source><volume>671</volume><fpage>103</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2018.05.091</pub-id><pub-id pub-id-type="pmid">29859289</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Du</surname><given-names>Z</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018c</year><article-title>LncRNA expression profiling of BMSCs in osteonecrosis of the femoral head associated with increased adipogenic and decreased osteogenic differentiation</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>9127</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-27501-2</pub-id><pub-id pub-id-type="pmid">29904151</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Ling</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Meng</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>AAV-Anti-miR-214 Prevents Collapse of the Femoral Head in Osteonecrosis by Regulating Osteoblast and Osteoclast Activities</article-title><source>Molecular Therapy. Nucleic Acids</source><volume>18</volume><fpage>841</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1016/j.omtn.2019.09.030</pub-id><pub-id pub-id-type="pmid">31739209</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysis</article-title><source>International Journal of Surgery</source><volume>69</volume><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.ijsu.2019.06.016</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>An animal model of early-stage femoral head osteonecrosis induced by cryo-insult in small tailed Han sheep</article-title><source>Journal of Orthopaedic Translation</source><volume>26</volume><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.jot.2020.06.004</pub-id><pub-id pub-id-type="pmid">33437627</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Luan</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Therapeutic effect of platelet-rich plasma on glucocorticoid-induced rat bone marrow mesenchymal stem cells in vitro</article-title><source>BMC Musculoskeletal Disorders</source><volume>23</volume><elocation-id>151</elocation-id><pub-id pub-id-type="doi">10.1186/s12891-022-05094-2</pub-id><pub-id pub-id-type="pmid">35168574</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Glucocorticoid-induced osteonecrosis</article-title><source>Endocrine</source><volume>41</volume><fpage>183</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1007/s12020-011-9580-0</pub-id><pub-id pub-id-type="pmid">22169965</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>Ge</surname><given-names>Q</given-names></name><name><surname>Zou</surname><given-names>Z</given-names></name><name><surname>Dong</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>C</given-names></name><name><surname>Ying</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Tong</surname><given-names>P</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Activation of β-catenin in Col2-expressing chondrocytes leads to osteoarthritis-like defects in hip joint</article-title><source>Journal of Cellular Physiology</source><volume>234</volume><fpage>18535</fpage><lpage>18543</lpage><pub-id pub-id-type="doi">10.1002/jcp.28491</pub-id><pub-id pub-id-type="pmid">30912140</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>C</given-names></name><name><surname>Ge</surname><given-names>Q</given-names></name><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Zou</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Lv</surname><given-names>S</given-names></name><name><surname>Tong</surname><given-names>P</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>P-E</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>TGF-β/Smad2 signalling regulates enchondral bone formation of Gli1<sup>+</sup> periosteal cells during fracture healing</article-title><source>Cell Proliferation</source><volume>53</volume><elocation-id>e12904</elocation-id><pub-id pub-id-type="doi">10.1111/cpr.12904</pub-id><pub-id pub-id-type="pmid">32997394</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>C</given-names></name><name><surname>Zou</surname><given-names>Z</given-names></name><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>Ge</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Tong</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>P-E</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Bushenhuoxue formula promotes osteogenic differentiation of growth plate chondrocytes through β-catenin-dependent manner during osteoporosis</article-title><source>Biomedicine &amp; Pharmacotherapy = Biomedecine &amp; Pharmacotherapie</source><volume>127</volume><elocation-id>110170</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2020.110170</pub-id><pub-id pub-id-type="pmid">32334373</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Weng</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Changed cellular functions and aberrantly expressed miRNAs and circRNAs in bone marrow stem cells in osteonecrosis of the femoral head</article-title><source>International Journal of Molecular Medicine</source><volume>45</volume><fpage>805</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.3892/ijmm.2020.4455</pub-id><pub-id pub-id-type="pmid">31922208</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>T</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cross-Talking between PPAR and WNT signaling and its regulation in mesenchymal stem cell differentiation</article-title><source>Current Stem Cell Research &amp; Therapy</source><volume>11</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.2174/1574888x10666150723145707</pub-id><pub-id pub-id-type="pmid">26201865</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Deasey</surname><given-names>MJ</given-names></name><name><surname>Cui</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Animal models of steroid-induced osteonecrosis of the femoral head-a comprehensive research review up to 2018</article-title><source>International Orthopaedics</source><volume>42</volume><fpage>1729</fpage><lpage>1737</lpage><pub-id pub-id-type="doi">10.1007/s00264-018-3956-1</pub-id><pub-id pub-id-type="pmid">29705870</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H-H</given-names></name><name><surname>Li</surname><given-names>S-M</given-names></name><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>Xia</surname><given-names>C-J</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Shi</surname><given-names>Z-Y</given-names></name><name><surname>Zou</surname><given-names>Z</given-names></name><name><surname>Ge</surname><given-names>Q-W</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Tong</surname><given-names>P-J</given-names></name><name><surname>Jin</surname><given-names>H-T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Platelet-rich plasma promotes bone formation, restrains adipogenesis and accelerates vascularization to relieve steroids-induced osteonecrosis of the femoral head</article-title><source>Platelets</source><volume>32</volume><fpage>950</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1080/09537104.2020.1810221</pub-id><pub-id pub-id-type="pmid">32835568</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>B</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Lv</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>LINC00473-modified bone marrow mesenchymal stem cells incorporated thermosensitive PLGA hydrogel transplantation for steroid-induced osteonecrosis of femoral head: A detailed mechanistic study and validity evaluation</article-title><source>Bioengineering &amp; Translational Medicine</source><volume>7</volume><elocation-id>e10275</elocation-id><pub-id pub-id-type="doi">10.1002/btm2.10275</pub-id><pub-id pub-id-type="pmid">35600648</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Tao</surname><given-names>H</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Geng</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Inhibition of MAGL activates the Keap1/Nrf2 pathway to attenuate glucocorticoid-induced osteonecrosis of the femoral head</article-title><source>Clinical and Translational Medicine</source><volume>11</volume><elocation-id>e447</elocation-id><pub-id pub-id-type="doi">10.1002/ctm2.447</pub-id><pub-id pub-id-type="pmid">34185425</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis</article-title><source>Chinese Medical Journal</source><volume>119</volume><fpage>581</fpage><lpage>588</lpage><pub-id pub-id-type="pmid">16620700</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Ge</surname><given-names>Z</given-names></name><name><surname>Dang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lithium prevents rat steroid-related osteonecrosis of the femoral head by β-catenin activation</article-title><source>Endocrine</source><volume>52</volume><fpage>380</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1007/s12020-015-0747-y</pub-id><pub-id pub-id-type="pmid">26458922</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Xuan</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Yao</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain</article-title><source>Journal of Bone and Mineral Metabolism</source><volume>36</volume><fpage>560</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1007/s00774-017-0873-0</pub-id><pub-id pub-id-type="pmid">29124436</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Luo</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Luo</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Rao</surname><given-names>P</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>PPARγ and Wnt signaling in adipogenic and osteogenic differentiation of mesenchymal stem cells</article-title><source>Current Stem Cell Research &amp; Therapy</source><volume>11</volume><fpage>216</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.2174/1574888x10666150519093429</pub-id><pub-id pub-id-type="pmid">25986621</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaidi</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Robinson</surname><given-names>LJ</given-names></name><name><surname>Tourkova</surname><given-names>IL</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>L-L</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Levine</surname><given-names>A</given-names></name><name><surname>Iqbal</surname><given-names>J</given-names></name><name><surname>Yaroslavskiy</surname><given-names>BB</given-names></name><name><surname>Isales</surname><given-names>C</given-names></name><name><surname>Blair</surname><given-names>HC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ACTH protects against glucocorticoid-induced osteonecrosis of bone</article-title><source>PNAS</source><volume>107</volume><fpage>8782</fpage><lpage>8787</lpage><pub-id pub-id-type="doi">10.1073/pnas.0912176107</pub-id><pub-id pub-id-type="pmid">20421485</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalavras</surname><given-names>C</given-names></name><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Birnbaum</surname><given-names>MJ</given-names></name><name><surname>Frenkel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis</article-title><source>Critical Reviews in Eukaryotic Gene Expression</source><volume>13</volume><fpage>221</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">14696969</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zou</surname><given-names>YL</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Dang</surname><given-names>XQ</given-names></name><name><surname>Wang</surname><given-names>KZ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Apoptosis associated with Wnt/β-catenin pathway leads to steroid-induced avascular necrosis of femoral head</article-title><source>BMC Musculoskeletal Disorders</source><volume>16</volume><elocation-id>132</elocation-id><pub-id pub-id-type="doi">10.1186/s12891-015-0606-2</pub-id><pub-id pub-id-type="pmid">26037065</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Dong</surname><given-names>R</given-names></name><name><surname>Xia</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>Zou</surname><given-names>Z</given-names></name><name><surname>Ge</surname><given-names>Q</given-names></name><name><surname>Tong</surname><given-names>P</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Yougui pills exert osteoprotective effects on rabbit steroid-related osteonecrosis of the femoral head by activating β-catenin</article-title><source>Biomedicine &amp; Pharmacotherapy = Biomedecine &amp; Pharmacotherapie</source><volume>120</volume><elocation-id>109520</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2019.109520</pub-id><pub-id pub-id-type="pmid">31629251</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X-Y</given-names></name><name><surname>Li</surname><given-names>H-N</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Y-P</given-names></name><name><surname>Chai</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>J-Z</given-names></name><name><surname>Gan</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>D-P</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y-Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Icariin regulates miR-23a-3p-mediated osteogenic differentiation of BMSCs via BMP-2/Smad5/Runx2 and WNT/β-catenin pathways in osteonecrosis of the femoral head</article-title><source>Saudi Pharmaceutical Journal</source><volume>29</volume><fpage>1405</fpage><lpage>1415</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2021.10.009</pub-id><pub-id pub-id-type="pmid">35002378</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>S-Y</given-names></name><name><surname>Goodman</surname><given-names>SB</given-names></name><name><surname>Hernigou</surname><given-names>P</given-names></name><name><surname>Cui</surname><given-names>Q</given-names></name><name><surname>Lineaweaver</surname><given-names>WC</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Drescher</surname><given-names>WR</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version)</article-title><source>Journal of Orthopaedic Translation</source><volume>21</volume><fpage>100</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.jot.2019.12.004</pub-id><pub-id pub-id-type="pmid">32309135</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Yeersheng</surname><given-names>R</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Hypoxia enhanced bone regeneration through the HIF-1α/β-catenin pathway in femoral head osteonecrosis</article-title><source>The American Journal of the Medical Sciences</source><volume>362</volume><fpage>78</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.amjms.2021.03.005</pub-id><pub-id pub-id-type="pmid">33727018</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L-Z</given-names></name><name><surname>Wang</surname><given-names>J-L</given-names></name><name><surname>Kong</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Pang</surname><given-names>Q-Q</given-names></name><name><surname>Wang</surname><given-names>X-L</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Steroid-associated osteonecrosis animal model in rats</article-title><source>Journal of Orthopaedic Translation</source><volume>13</volume><fpage>13</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.jot.2018.01.003</pub-id><pub-id pub-id-type="pmid">29662787</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Gan</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CD41-deficient exosomes from non-traumatic femoral head necrosis tissues impair osteogenic differentiation and migration of mesenchymal stem cells</article-title><source>Cell Death &amp; Disease</source><volume>11</volume><elocation-id>293</elocation-id><pub-id pub-id-type="doi">10.1038/s41419-020-2496-y</pub-id><pub-id pub-id-type="pmid">32341357</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92469.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ji</surname><given-names>Yaoting</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Wuhan University</institution><country>China</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>This study presents <bold>valuable</bold> findings on the mechanism of glucocorticoid-induced osteonecrosis of the femoral head. The data were collected and analyzed using <bold>solid</bold>, validated methodology and can be used as a starting point for functional studies of development of glucocorticoid-induced osteonecrosis. This article would be of interest to cell biologists and biophysicists working on potential pharmacological treatments for glucocorticoid-induced osteonecrosis.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92469.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The manuscript by Xia et al. investigated the mechanisms underlying Glucocorticoid-induced osteonecrosis of the femoral head (GONFH). The authors observed that abnormal osteogenesis and adipogenesis is associated with decreased β-catenin in the necrotic femoral head of GONFH patients and inhibition of β-catenin signaling leads to abnormal osteogenesis and adipogenesis in GONFH rats. Of interest, deletion of β-catenin in Col2-expressing cells rather than in osx-expressing cells leads to a GONFH-like phenotype in femoral head of mice.</p><p>Strengths:</p><p>A strength of the study is that it sets up a Col2-expressing cell-specific β-catenin knockout mouse model that mimics full spectrum of osteonecrosis phenotype of GONFH. This is interesting and provides new insights into the understanding of GONFH. Overall, the data are solid and support their conclusions.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92469.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this manuscript, the authors reported a study to uncover that β-catenin inhibition disrupting the homeostasis of osteogenic/adipogenic differentiation contributes to the development of Glucocorticoid-induced osteonecrosis of the femoral head (GONFH). In this study, they first observed abnormal osteogenesis and adipogenesis associated with decreased β-catenin in the necrotic femoral head of GONFH patients, but the exact pathological mechanisms of GONFH remain unknown. They then performed in vivo and in vitro studies to further revealed that glucocorticoid exposure disrupted osteogenic/adipogenic differentiation bone marrow stromal cells (BMSCs) by inhibiting β-catenin signaling in glucocorticoid-induced GONFH rats, and specific deletion of β-catenin in Col2+ cells shifted BMSCs commitment from osteoblasts to adipocytes, leading to a full spectrum of disease phenotype of GONFH in adult mice.</p><p>Strengths:</p><p>This innovative study provides strong evidence supporting that β-catenin inhibition disrupts the homeostasis of osteogenic/adipogenic differentiation that contributes to the development of GONFH. This study also identifies an ideal genetic modified mouse model of GONFH. Overall, the experiment is logically designed, the figures are clear, and the data generated from humans and animals is abundant supporting their conclusions.</p><p>Weaknesses:</p><p>Lack of the discussion to explain how the Wnt agonist 1 works. There are several types of Wnt ligands. It is not clear if this agonist only targets Wnt1 or other Wnts as well? Also, why Wnt agonist 1 couldn't rescue the GONFH-like phenotype in β-cateninCol2ER mice needs to be discussed.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92469.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this manuscript, the authors are trying to delineate the mechanism underlying the osteonecrosis of the femoral head.</p><p>Strengths:</p><p>The authors provided compelling in vivo and in vitro data to demonstrate Col2+ cells and Osx+ cells were differentially expressed in the</p><p>the femoral head. Moreover, inducible knockout of β-catenin in Col2+ cells but not</p><p>Osx+ cells lead to a GONFH-like phenotype including fat accumulation, subchondral</p><p>bone destruction and femoral head collapse, indicating that imbalance of osteogenic/adipogenic differentiation of Col2+ cells play an important role in GONFH pathogenesis. Therefore, this manuscript provided the mechanistic insights of osteonecrosis as well as potential therapeutic target for disease treatment.</p><p>Weaknesses: Additional in depth discussion regarding the phenotype observed in mice is highly encouraged.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92469.3.sa4</article-id><title-group><article-title>Author Response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xia</surname><given-names>Chenjie</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Ningbo</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Huihui</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Fang</surname><given-names>Liang</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Jiali</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Wenhua</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Danqing</given-names></name><role specific-use="author">Author</role><aff><institution>School of Basic Medical Sciences, Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xucheng</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Bangjian</given-names></name><role specific-use="author">Author</role><aff><institution>the First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xiao</surname><given-names>Luwei</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Chengliang</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Tong</surname><given-names>Peijian</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Di</given-names></name><role specific-use="author">Author</role><aff><institution>Chinese Academy of Sciences</institution><addr-line><named-content content-type="city">Shenzhen</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Pinger</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Jin</surname><given-names>Hongting</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Zhejiang Chinese Medical University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>The manuscript by Xia et al. investigated the mechanisms underlying Glucocorticoid-induced osteonecrosis of the femoral head (GONFH). The authors observed that abnormal osteogenesis and adipogenesis are associated with decreased β-catenin in the necrotic femoral head of GONFH patients, and that the inhibition of β-catenin signalling leads to abnormal osteogenesis and adipogenesis in GONFH rats. Of interest, the deletion of β-catenin in Col2-expressing cells rather than in Osx-expressing cells leads to a GONFH-like phenotype in the femoral head of mice.</p><p>Strengths:</p><p>A strength of the study is that it sets up a Col2-expressing cell-specific β-catenin knockout mouse model that mimics the full spectrum of osteonecrosis phenotype of GONFH. This is interesting and provides new insights into the understanding of GONFH. Overall, the data are solid and support their conclusions.</p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>1. Fig. 1I should be quantified and presented as bar graphs to make it consistent with other data, and the significance should be shown.</p></disp-quote><p>Reply: Thanks for your comments. We have provided the quantitative bar graph in the new version.</p><disp-quote content-type="editor-comment"><p>1. Fig. 2H, beta-catenin, ALP and FABP4 should be labled below the X axis. Moreover, the pattern of Fig. 2H is different from other bar graphs and the dots for individual samples are missing, so I could not judge the N values for the experiments. N values should also be provided for Fig. 3.</p></disp-quote><p>Reply: Thanks for your comments. We have added the labels of beta-catenin, ALP and FABP4 below the X axis in Fig. 2H. The modes of quantitative bar graphs were changed to show the N values in the each experiment.</p><disp-quote content-type="editor-comment"><p>1. Fig. 4 shows the fate mapping of Col2+ cells and Osx+ cells in the femoral head. In this regard, the authors presented images for Col2-expressing cells at all the indicated time points, i.e. 1, 3, 6, and 9 months, but only presented images for Osx-expressing cells for 1 month while those for 3, 6, and 9 months are missing.</p></disp-quote><p>Reply: Thanks for your comments. Here, we showed that the expression of Osx+ cells in the femoral head were total different with Col2+ cells at the age of 3, 6 month, further indicating they were two different progenitor lineage cells.</p><fig id="sa4fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92469-sa4-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>1. Some experiments may need to be described in more detail&quot; e.g., ABH/Orange G staining, biomechanical testing, μCT analysis, et al.</p></disp-quote><p>Reply: Thanks for your comments. We have provided more information of experiment procedures.</p><disp-quote content-type="editor-comment"><p>1. This study proposed that Col2-expressing cells play a key role in the progression of GONFH, did the authors use Col2+ cells for the in vitro experiments?</p></disp-quote><p>Reply: As in vitro experiments could not reflect the location of Col2-expressing cells in the femoral head, therefore here we applied in vivo lineage tracing study. After as long as 9 month of linage trace, we thoroughly showed the self-renew ability and osteogenic commitment of Col2+ cells, as well as its space variation in the femoral head with age. Conditional knockout of β-catenin caused that Col2+ cells trans-differentiated into adipogenic cells instead of osteogenic cells, which directly clarified the mechanism of Col2+ cells leading to GONFH-like phenotype in mice.</p><disp-quote content-type="editor-comment"><p>1. A few typo errors, such as Line 13, &quot;contribute&quot; should be &quot;contributes&quot;; Line 118, &quot;reveled&quot; should be &quot;revealed&quot;.</p></disp-quote><p>Reply: We have revised the grammar errors in the new manuscript.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>In this manuscript, the authors reported a study to uncover that β-catenin inhibition disrupting the homeostasis of osteogenic/adipogenic differentiation contributes to the development of Glucocorticoid-induced osteonecrosis of the femoral head (GONFH). In this study, they first observed abnormal osteogenesis and adipogenesis associated with decreased β-catenin in the necrotic femoral head of GONFH patients, but the exact pathological mechanisms of GONFH remain unknown. They then performed in vivo and in vitro studies to further reveal that glucocorticoid exposure disrupted osteogenic/adipogenic differentiation of bone marrow stromal cells (BMSCs) by inhibiting β-catenin signaling in glucocorticoid-induced GONFH rats, and specific deletion of β-catenin in Col2+ cells shifted BMSCs commitment from osteoblasts to adipocytes, leading to a full spectrum of disease phenotype of GONFH in adult mice.</p><p>Strengths:</p><p>This innovative study provides strong evidence supporting that β-catenin inhibition disrupts the homeostasis of osteogenic/adipogenic differentiation that contributes to the development of GONFH. This study also identifies an ideal genetically modified mouse model of GONFH. Overall, the experiment is logically designed, the figures are clear, and the data generated from humans and animals is abundant supporting their conclusions.</p><p>Weaknesses:</p><p>There is a lack of discussion to explain how the Wnt agonist 1 works. There are several types of Wnt ligands. It is not clear if this agonist only targets Wnt1 or other Wnts as well. Also, why Wnt agonist 1 couldn't rescue the GONFH-like phenotype in β-cateninCol2ER mice needs to be discussed.</p></disp-quote><p>Reply: Thanks for your constructive comments. Wnt agonist 1 is a cell-permeating activator of the Wnt signaling pathway that induces transcriptional activity dependent on β-catenin (PMID: 25514428,18624906). In the present study, we aim to demonstrate that activation of β-catenin signaling could alleviate the phenotype of rat GONFH, thus only β-catenin and downstream targets (RUNX2, ALP, PPAR-γ, FABP4) expressions were detected after Wnt agonist 1 intervention. Conditional knockout β-catenin in Col2+ cells lead to an mouse GONFH-like phenotype. Wnt agonist 1 couldn't rescue this GONFH-like, as it did not activate β-catenin signaling. We have discussed them in the new version.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public Review):</bold></p><p>Summary:</p><p>In this manuscript, the authors are trying to delineate the mechanism underlying the osteonecrosis of the femoral head.</p><p>Strengths:</p><p>The authors provided compelling in vivo and in vitro data to demonstrate Col2+ cells and Osx+ cells were differentially expressed in the femoral head. Moreover, inducible knockout of β-catenin in Col2+ cells but not Osx+ cells lead to a GONFH-like phenotype including fat accumulation, subchondral bone destruction, and femoral head collapse, indicating that imbalance of osteogenic/adipogenic differentiation of Col2+ cells plays an important role in GONFH pathogenesis. Therefore, this manuscript provided mechanistic insights into osteonecrosis as well as potential therapeutic targets for disease treatment.</p><p>Weaknesses:</p><p>However, additional in-depth discussion regarding the phenotype observed in mice is highly encouraged.</p></disp-quote><p>Reply: Thanks for your comments. Inducible knockout of β-catenin in Col2+ cells but not Osx+ cells lead to a GONFH-like phenotype. Lineage tracing data showed Col2+ cells and Osx+ cells were different cell populations, and we have discussed the potential mechanism caused the different phenotypes between β-cateninCol2ER mice and β-cateninOsxER mice.</p><disp-quote content-type="editor-comment"><p>1. Why did the authors use dexamethasone in the cellular experiments but methylprednisolone to induce the GONFH rat model?</p></disp-quote><p>Reply: Thanks for the comments. Here, we applied a dexamethasone (DEX)-treated BMSC model in vitro and a methylprednisolone (MPS)-induced rat model in vivo for GONFH study based on the published literatures (PMID: 37317020, 29662787, 29512684,35126710, 32835568).</p><disp-quote content-type="editor-comment"><p>1. Both bone damage and fat accumulation were observed in 3-month-old and 6-month-old β-cateninCol2ER mice, but the femoral head collapse (the feature of GONFH at the late stage) only occurred in the older β-catenin Col2ER mice. This interesting observation needs to be discussed.Reply: Thanks for the comments. Bone damage caused a poor mechanical support is the key to femoral head collapse. Despite of similar trabecular bone loss and fat accumulation in the 3-month-old and 6-month-old β-cateninCol2ER mice, the older mice also presented extensive subchondral bone destruction. Integrated subchondral bone provided a well mechanical support for femoral head morphology, therefore femoral head collapse were occurred in the older β-cateninCol2ER mice.</p><p>1. In the Materials and Methods, detailed information on the reagents should be provided.</p></disp-quote><p>Reply: We have provided detailed information of the important reagents.</p><disp-quote content-type="editor-comment"><p>1. As shown in Figure 4, β-cateninOsxER mice at 3 months of age did not show differences in lipid droplet area and empty lacunae rate, but there was a decrease in bone area. The authors should at least provide some necessary discussion of this phenomenon.</p></disp-quote><p>Reply: Thanks for your comments. In the present study, we found few lipid droplet and empty lacuna but a significant decrease of bone mass in the femoral heads of β-cateninOsxER mice. Previous studies showed that specific knockout of β-catenin in Osx-expressing cells promoted osteoclast formation and activity, leading to the bone mass loss (PMID: 29124436, 34973494). We discussed this phenomenon in the new version.</p></body></sub-article></article>